Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	12898378	12898378	C	G	intergenic	PRAMEF11;HNRNPCL1	dist=7114;dist=8852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	245	chr1	12898378	chr1:12898378	C	G	113	PASS	AN=2;DP=245	GT	0/1
chr1	12898654	12898654	A	G	intergenic	PRAMEF11;HNRNPCL1	dist=7390;dist=8576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	150	chr1	12898654	chr1:12898654	A	G	111	PASS	AN=2;DP=150	GT	0/1
chr1	12908080	12908080	C	T	exonic	HNRNPCL1;HNRNPCL3;HNRNPCL4	.	synonymous SNV	HNRNPCL3:NM_001146181:exon1:c.G63A:p.G21G,HNRNPCL4:NM_001302551:exon1:c.G63A:p.G21G,HNRNPCL1:NM_001013631:exon2:c.G63A:p.G21G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	200	chr1	12908080	chr1:12908080	C	T	134	PASS	AN=2;DP=200	GT	0/1
chr1	12921132	12921132	A	G	exonic	PRAMEF2	.	nonsynonymous SNV	PRAMEF2:NM_023014:exon4:c.A923G:p.E308G	0.00056761	0.708417519	0.291014871	.	0.07552	.	5.208541975	99.84076433	3268.27865	10.91295	0.064	0.365	T	0.38	0.326	B	0.228	0.364	B	0.328	0.041	N	1	0.090	P	1.63	0.419	L	0.79	0.491	T	-1.45	0.356	N	0.091	0.089	-1.097	0.045	T	0.001	0.003	T	.	.	.	1.316	0.222	12.35	0.921	0.209	0.001	0.008	N	c	-1.054	-1.268	0.000	0.012	0.487	0.133	0	-1.65	0.078	-1.150	0.033	0.579	0.285	0.000	0.063	0.008	0.104	1.446	0.022	Leucine-rich repeat domain, L domain-like	.	.	0.5	80	117	chr1	12921132	chr1:12921132	A	G	80	PASS	AN=2;DP=117	GT	0/1
chr1	12942138	12942138	C	G	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon3:c.G412C:p.E138Q	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	0.494	0.079	T	0.0	0.026	B	0.0	0.013	B	0.008	0.012	N	1	0.090	P	-0.145	0.044	N	3.35	0.060	T	0.42	0.034	N	0.126	0.193	-0.908	0.471	T	0.000	0.000	T	.	.	.	-2.714	0.002	0.001	0.156	0.004	0.001	0.008	N	c	-1.956	-2.088	0.005	0.107	0.487	0.133	0	-2.4	0.062	-0.634	0.055	-1.273	0.014	0.000	0.063	0.000	0.016	2.286	0.038	.	.	.	0.5	125	79	chr1	12942138	chr1:12942138	C	G	125	PASS	AN=2;DP=79	GT	0/1
chr1	13414093	13414093	A	G	exonic	PRAMEF10;PRAMEF33	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	338	chr1	13414093	chr1:13414093	A	G	95	PASS	AN=2;DP=338	GT	0/1
chr1	16975411	16975411	G	C	ncRNA_exonic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	158	chr1	16975411	chr1:16975411	G	C	114	PASS	AN=2;DP=158	GT	0/1
chr1	17698725	17698725	C	T	UTR5	PADI6	NM_207421:c.-16C>T	.	.	.	.	.	.	0.06559	0.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	141	chr1	17698725	chr1:17698725	C	T	78	PASS	AN=2;DP=141	GT	0/1
chr1	20662938	20662938	A	G	exonic	VWA5B1	.	nonsynonymous SNV	VWA5B1:NM_001039500:exon13:c.A1901G:p.K634R	.	.	.	.	.	.	.	.	7561.17588	18.64813	0.259	0.166	T	0.013	0.247	B	0.003	0.184	B	0.958	0.082	N	1	0.090	P	1.39	0.351	L	2.53	0.140	T	-0.73	0.206	N	0.021	0.109	-0.902	0.478	T	0.000	0.000	T	.	.	.	-0.662	0.047	0.089	0.874	0.167	0.031	0.080	N	c	-1.133	-1.169	0.004	0.106	0.534	0.214	0	-2.08	0.068	0.106	0.151	1.076	0.850	0.000	0.063	0.270	0.232	4.499	0.112	.	.	.	0.5	72	103	chr1	20662938	chr1:20662938	A	G	72	PASS	AN=2;DP=103	GT	0/1
chr1	22304831	22304831	C	A	intronic	CELA3B	.	.	.	2.12E-10	0.035783176	0.964216824	.	0.26327	.	1.732552414	96.59707478	690.96911	5.24243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	170	623	chr1	22304831	chr1:22304831	C	A	170	PASS	AN=2;DP=623	GT	0/1
chr1	44072066	44072066	C	T	exonic	PTPRF	.	synonymous SNV	PTPRF:NM_001329140:exon17:c.C2727T:p.P909P,PTPRF:NM_001329139:exon18:c.C2754T:p.P918P,PTPRF:NM_130440:exon19:c.C3612T:p.P1204P,PTPRF:NM_001329137:exon20:c.C2772T:p.P924P,PTPRF:NM_002840:exon20:c.C3639T:p.P1213P,PTPRF:NM_001329138:exon21:c.C2784T:p.P928P	0.999998379	1.62E-06	5.73E-19	DISEASE: Aplasia or hypoplasia of the breasts and/or nipples 2 (BNAH2) [MIM:616001]: A group of congenital deformities encompassing total absence of breasts and nipple (amastia), absence of the nipple (athelia), and absence of the mammary gland (amazia). {ECO:0000269|PubMed:24781087}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30877	0.14232	-3.924965486	0.20051899	258.69725	3.45757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	201	chr1	44072066	chr1:44072066	C	T	78	PASS	AN=2;DP=201	GT	0/1
chr1	53527948	53527948	T	G	exonic	PODN	.	synonymous SNV	PODN:NM_153703:exon1:c.T57G:p.P19P	5.20E-07	0.853425189	0.146574291	.	0.2183	0.10789	0.027580343	55.8091531	1753.94189	7.72811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	210	chr1	53527948	chr1:53527948	T	G	102	PASS	AN=2;DP=210	GT	0/1
chr1	110257814	110257814	G	C	exonic	GSTM5	.	nonsynonymous SNV	GSTM5:NM_000851:exon7:c.G519C:p.K173N	0.000214167	0.736990281	0.262795552	.	0.04393	.	0.905808022	89.4373673	506.91274	4.62021	0.145	0.313	T	0.0	0.067	B	0.012	0.149	B	0.047	0.233	U	1.000	0.194	N	2.685	0.788	M	4.55	0.020	T	-2.05	0.545	N	0.052	0.111	-0.943	0.421	T	0.003	0.011	T	.	.	.	-0.413	0.061	0.360	0.849	0.150	0.111	0.162	N	c	-0.989	-1.078	0.003	0.095	0.615	0.372	0	-0.563	0.111	0.400	0.205	-2.819	0.002	0.219	0.243	0.000	0.016	4.434	0.109	Glutathione S-transferase, C-terminal|Glutathione S-transferase, C-terminal-like	.	.	0.5	67	94	chr1	110257814	chr1:110257814	G	C	67	PASS	AN=2;DP=94	GT	0/1
chr1	143210293	143210293	T	C	intergenic	LOC102723769;MIR6077	dist=8054;dist=462628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	115	chr1	143210293	chr1:143210293	T	C	138	PASS	AN=2;DP=115	GT	0/1
chr1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	109	223	chr1	144856817	chr1:144856817	T	C	109	PASS	AN=2;DP=223	GT	0/1
chr1	145074975	145074975	G	A	intronic	NBPF19;NBPF20;NBPF9;PDE4DIP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	138	chr1	145074975	chr1:145074975	G	A	99	PASS	AN=2;DP=138	GT	0/1
chr1	146420082	146420082	T	G	exonic	NBPF12;NBPF20	.	nonsynonymous SNV	NBPF12:NM_001278141:exon25:c.T2730G:p.C910W,NBPF20:NM_001278267:exon100:c.T11052G:p.C3684W	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	P	2.015	0.552	M	.	.	.	.	.	.	0.229	0.317	-0.958	0.396	T	0.011	0.040	T	.	.	.	1.893	0.288	15.55	0.967	0.303	0.004	0.021	N	c	-0.773	-1.018	0.000	0.012	0.693	0.558	0	-1.04	0.095	0.049	0.139	0.458	0.278	0.001	0.137	0.003	0.074	3.410	0.069	Neuroblastoma breakpoint family (NBPF) domain	ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2	Adipose_Subcutaneous|Artery_Tibial|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Lung|Nerve_Tibial|Pancreas|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid	0.5	84	116	chr1	146420082	chr1:146420082	T	G	84	PASS	AN=2;DP=116	GT	0/1
chr1	148004649	148004649	C	G	exonic	NBPF26	.	nonsynonymous SNV	NBPF26:NM_001351372:exon30:c.G3910C:p.E1304Q	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	228	chr1	148004649	chr1:148004649	C	G	106	PASS	AN=2;DP=228	GT	0/1
chr1	152277345	152277345	C	T	exonic	FLG	.	synonymous SNV	FLG:NM_002016:exon3:c.G10017A:p.Q3339Q	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	193	chr1	152277345	chr1:152277345	C	T	94	PASS	AN=2;DP=193	GT	0/1
chr1	205496983	205496983	G	A	exonic	CDK18	.	nonsynonymous SNV	CDK18:NM_002596:exon9:c.G791A:p.R264Q,CDK18:NM_212502:exon9:c.G791A:p.R264Q,CDK18:NM_212503:exon9:c.G881A:p.R294Q	7.16E-08	0.692723341	0.307276588	.	0.32808	0.13832	0.198490371	67.30360934	867.92025	5.73904	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.145	0.976	H	-0.12	0.646	T	-3.85	0.723	D	0.985	0.988	0.535	0.910	D	0.597	0.856	D	0.597	0.965	D	7.683	0.954	35	1.000	1.000	0.985	0.835	D	c	1.043	0.936	1.000	0.747	0.626	0.397	0	4.95	0.648	9.921	0.988	1.047	0.674	1.000	0.715	0.955	0.433	16.746	0.853	Protein kinase domain|Protein kinase-like domain;Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	84	179	chr1	205496983	chr1:205496983	G	A	84	PASS	AN=2;DP=179	GT	0/1
chr1	214503489	214503489	T	G	intronic	SMYD2	.	.	.	0.005368937	0.989356107	0.005274956	.	0.23384	0.10894	0.352813824	74.49280491	200.10993	3.05629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	110	chr1	214503489	chr1:214503489	T	G	78	PASS	AN=2;DP=110	GT	0/1
chr1	243328887	243328887	G	T	exonic	CEP170	.	stopgain	CEP170:NM_001042404:exon12:c.C2081A:p.S694X,CEP170:NM_001042405:exon12:c.C2081A:p.S694X,CEP170:NM_014812:exon13:c.C2375A:p.S792X	.	.	.	.	0.51507	0.12994	-0.26629572	34.81953291	653.42753	5.12884	.	.	.	.	.	.	.	.	.	0.816	0.092	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.821	0.956	35	0.989	0.478	0.750	0.364	D	c	0.442	0.135	0.001	0.082	0.732	0.924	0	0.747	0.174	2.208	0.422	0.140	0.223	0.509	0.268	0.491	0.269	6.963	0.236	.	.	.	0.5	65	80	chr1	243328887	chr1:243328887	G	T	65	PASS	AN=2;DP=80	GT	0/1
chr1	247241850	247241850	G	C	ncRNA_intronic	ZNF670-ZNF695	.	.	.	.	.	.	.	0.07638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	455	chr1	247241850	chr1:247241850	G	C	109	PASS	AN=2;DP=455	GT	0/1
chr1	248224216	248224216	C	T	exonic	OR2L3	.	nonsynonymous SNV	OR2L3:NM_001004687:exon1:c.C233T:p.P78L	6.39E-05	0.283107845	0.716828238	.	0.04593	0.09315	1.128108522	92.19155461	2290.45899	8.85807	0.004	0.654	D	0.969	0.548	D	0.883	0.609	P	0.007	0.315	U	1e-37	0.810	P	3.75	0.951	H	4.6	0.019	T	-9.35	0.983	D	0.299	0.359	-0.993	0.320	T	0.000	0.000	T	.	.	.	5.460	0.741	26.1	0.995	0.697	0.866	0.456	D	c	0.370	0.158	0.556	0.214	0.487	0.133	0	2.05	0.257	3.362	0.518	0.498	0.280	0.985	0.357	0.004	0.083	11.965	0.521	GPCR, rhodopsin-like, 7TM	.	.	0.5	77	96	chr1	248224216	chr1:248224216	C	T	77	PASS	AN=2;DP=96	GT	0/1
chr1	248224754	248224754	T	C	exonic	OR2L3	.	synonymous SNV	OR2L3:NM_001004687:exon1:c.T771C:p.T257T	6.39E-05	0.283107845	0.716828238	.	0.04593	0.09315	1.128108522	92.19155461	2290.45899	8.85807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	114	chr1	248224754	chr1:248224754	T	C	108	PASS	AN=2;DP=114	GT	0/1
chr2	89278489	89278489	A	C	intergenic	MIR4436A;NONE	dist=166521;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	203	chr2	89278489	chr2:89278489	A	C	115	PASS	AN=2;DP=203	GT	0/1
chr2	89292182	89292182	A	G	intergenic	MIR4436A;NONE	dist=180214;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	75	chr2	89292182	chr2:89292182	A	G	105	PASS	AN=2;DP=75	GT	0/1
chr2	89292401	89292401	T	C	intergenic	MIR4436A;NONE	dist=180433;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	111	chr2	89292401	chr2:89292401	T	C	87	PASS	AN=2;DP=111	GT	0/1
chr2	89309542	89309542	T	G	intergenic	MIR4436A;NONE	dist=197574;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	86	chr2	89309542	chr2:89309542	T	G	94	PASS	AN=2;DP=86	GT	0/1
chr2	89309554	89309554	T	A	intergenic	MIR4436A;NONE	dist=197586;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	86	chr2	89309554	chr2:89309554	T	A	84	PASS	AN=2;DP=86	GT	0/1
chr2	89309762	89309762	T	G	intergenic	MIR4436A;NONE	dist=197794;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	76	chr2	89309762	chr2:89309762	T	G	114	PASS	AN=2;DP=76	GT	0/1
chr2	90121985	90121985	A	G	intergenic	MIR4436A;LOC654342	dist=1010017;dist=1702724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	67	chr2	90121985	chr2:90121985	A	G	99	PASS	AN=2;DP=67	GT	0/1
chr2	98205924	98205924	C	G	intronic	ANKRD36B	.	.	.	.	.	.	.	0.28221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	250	chr2	98205924	chr2:98205924	C	G	101	PASS	AN=2;DP=250	GT	0/1
chr2	130951848	130951848	T	C	exonic	TUBA3E	.	synonymous SNV	TUBA3E:NM_207312:exon4:c.A567G:p.L189L	0.001205278	0.846489817	0.152304904	.	0.51437	0.17173	0.378498378	75.58386412	520.54799	4.65963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	154	chr2	130951848	chr2:130951848	T	C	124	PASS	AN=2;DP=154	GT	0/1
chr2	220173905	220173905	C	T	intronic	PTPRN	.	.	.	0.021748201	0.978223608	2.82E-05	DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8144912, ECO:0000269|PubMed:8641276}.; 	0.5043	0.3225	-1.392555112	4.269874971	262.5746	3.47632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	246	chr2	220173905	chr2:220173905	C	T	85	PASS	AN=2;DP=246	GT	0/1
chr2	233413825	233413825	G	A	exonic	TIGD1	.	synonymous SNV	TIGD1:NM_145702:exon1:c.C768T:p.P256P	.	.	.	.	.	.	.	.	119.93261	2.38592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	144	chr2	233413825	chr2:233413825	G	A	67	PASS	AN=2;DP=144	GT	0/1
chr2	234656517	234656517	T	C	intronic	UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	125	chr2	234656517	chr2:234656517	T	C	70	PASS	AN=2;DP=125	GT	0/1
chr3	9860595	9860595	G	A	exonic	TTLL3	.	nonsynonymous SNV	TTLL3:NM_001025930:exon6:c.G949A:p.E317K	3.84E-14	0.080133074	0.919866926	.	.	0.0989	-0.214928658	37.7388535	1000.48997	6.0936	0.131	0.912	T	0.013	0.203	B	0.007	0.203	B	0.726	0.063	U	1.000	0.189	N	0.55	0.145	N	3.6	0.386	T	-1.79	0.461	N	0.327	0.449	-1.045	0.159	T	0.042	0.181	T	.	.	.	1.365	0.228	12.61	0.811	0.131	0.086	0.143	N	c	-0.426	-0.549	0.748	0.233	0.707	0.730	0	1.87	0.244	1.865	0.389	0.998	0.613	0.024	0.198	0.065	0.173	6.221	0.198	.	.	.	0.5	65	97	chr3	9860595	chr3:9860595	G	A	65	PASS	AN=2;DP=97	GT	0/1
chr3	40468859	40468859	C	G	exonic	ENTPD3	.	nonsynonymous SNV	ENTPD3:NM_001248:exon11:c.C1450G:p.P484A,ENTPD3:NM_001291960:exon11:c.C1450G:p.P484A	2.56E-19	0.000141873	0.999858127	.	0.16865	0.16922	-0.26629572	34.81953291	1007.34812	6.11352	0.281	0.154	T	0.932	0.500	P	0.396	0.426	B	0.026	0.260	N	1	0.090	N	0.895	0.225	L	2.95	0.097	T	-2.65	0.567	D	0.348	0.409	-1.008	0.276	T	0.014	0.055	T	0.006	0.166	T	0.539	0.146	7.724	0.962	0.285	0.334	0.246	N	c	-0.354	-0.368	0.980	0.301	0.487	0.133	0	4.29	0.502	2.197	0.421	0.935	0.490	0.011	0.184	0.281	0.234	7.728	0.278	.	.	.	0.5	97	93	chr3	40468859	chr3:40468859	C	G	97	PASS	AN=2;DP=93	GT	0/1
chr3	56835761	56835761	G	A	exonic	ARHGEF3	.	synonymous SNV	ARHGEF3:NM_019555:exon1:c.C66T:p.P22P	0.991271358	0.008728557	8.58E-08	.	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	197	353	chr3	56835761	chr3:56835761	G	A	197	PASS	AN=2;DP=353	GT	1/0
chr3	119395799	119395799	A	C	intronic	COX17	.	.	.	0.515141893	0.41831768	0.066540427	.	0.28472	0.1942	0.101211609	60.95777306	712.96801	5.30525	0.004	0.654	D	.	.	.	.	.	.	.	.	.	1	0.186	P	.	.	.	.	.	.	-0.19	0.100	N	0.07	0.058	-0.958	0.395	T	0.000	0.000	T	.	.	.	0.191	0.112	4.585	0.783	0.118	0.042	0.095	N	c	-0.529	-0.702	1.000	0.747	0.442	0.072	0	2.15	0.265	-0.315	0.081	1.088	0.866	0.000	0.063	0.003	0.074	5.117	0.141	.	ENSG00000138495.2|ENSG00000242052.1|ENSG00000183833.12|ENSG00000138495.2|ENSG00000138495.2|ENSG00000242052.1|ENSG00000242052.1|ENSG00000242052.1|ENSG00000183833.12|ENSG00000242052.1|ENSG00000183833.12|ENSG00000183833.12|ENSG00000183833.12|ENSG00000138495.2|ENSG00000183833.12|ENSG00000242052.1	Adipose_Subcutaneous|Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Colon_Sigmoid|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Thyroid	0.5	85	98	chr3	119395799	chr3:119395799	A	C	85	PASS	AN=2;DP=98	GT	0/1
chr3	195717077	195717077	-	GCGCCAG	ncRNA_exonic	SDHAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	100	chr3	195717077	chr3:195717077	A	AGCGCCAG	115	PASS	AN=2;DP=100	GT	0/1
chr3	195978246	195978246	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	80	chr3	195978246	chr3:195978246	T	C	81	PASS	AN=2;DP=80	GT	0/1
chr4	88048163	88048163	-	T	intronic	AFF1	.	.	.	0.476646973	0.523352667	3.61E-07	DISEASE: Note=A chromosomal aberration involving AFF1 is associated with acute leukemias. Translocation t(4;11)(q21;q23) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.0974	0.1848	-1.183251814	5.909412597	190.31308	2.99434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	63	chr4	88048163	chr4:88048163	A	AT	116	PASS	AN=2;DP=63	GT	0/1
chr4	100263965	100263965	C	T	exonic	ADH1C	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	0.002	0.090	B	0.008	0.127	B	.	.	.	.	.	.	1.365	0.343	L	.	.	.	.	.	.	0.126	0.320	.	.	.	.	.	.	.	.	.	4.526	0.606	24.3	0.995	0.669	0.024	0.067	N	n	0.705	-0.044	0.000	0.012	0.061	0.009	0	1.77	0.237	0.447	0.213	-0.374	0.066	0.005	0.169	0.317	0.240	5.700	0.170	Alcohol dehydrogenase, C-terminal|NAD(P)-binding domain	ENSG00000248144.1|ENSG00000198099.4|ENSG00000248144.1|ENSG00000248144.1|ENSG00000248144.1|ENSG00000248144.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Brain_Putamen_basal_ganglia|Esophagus_Mucosa|Heart_Atrial_Appendage|Heart_Left_Ventricle	0.5	60	74	chr4	100263965	chr4:100263965	C	T	60	PASS	AN=2;DP=74	GT	0/1
chr4	100266112	100266112	C	T	exonic	ADH1C	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	113	chr4	100266112	chr4:100266112	C	T	65	PASS	AN=2;DP=113	GT	0/1
chr4	100268132	100268132	A	C	intronic	ADH1C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	61	chr4	100268132	chr4:100268132	A	C	66	PASS	AN=2;DP=61	GT	0/1
chr4	100784134	100784134	C	G	intronic	DAPP1	.	.	.	0.18349368	0.804567476	0.011938844	.	0.18283	0.11376	-0.075159878	47.78839349	10.06314	0.36728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	150	chr4	100784134	chr4:100784134	C	G	96	PASS	AN=2;DP=150	GT	0/1
chr4	185687687	185687687	A	C	intronic	ACSL1	.	.	.	0.091837331	0.908159695	2.97E-06	.	0.24765	0.32858	-0.841329384	11.36470866	62.62006	1.61892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	72	chr4	185687687	chr4:185687687	A	C	67	PASS	AN=2;DP=72	GT	0/1
chr4	190878664	190878664	A	G	intronic	FRG1	.	.	.	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	270	chr4	190878664	chr4:190878664	A	G	110	PASS	AN=2;DP=270	GT	0/1
chr5	796015	796015	A	C	UTR3	ZDHHC11	NM_024786:c.*688T>G	.	.	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	.	.	.	.	.	.	.	.	.	.	.	.	0.994	0.422	D	.	.	.	.	.	.	.	.	.	.	.	-0.904	0.475	T	0.173	0.516	T	.	.	.	-0.255	0.072	0.839	0.492	0.041	0.066	0.125	N	c	-0.611	-0.824	0.000	0.052	0.258	0.037	0	1.07	0.193	-1.126	0.033	-0.703	0.037	0.000	0.063	0.002	0.062	3.397	0.068	.	.	.	0.5	122	65	chr5	796015	chr5:796015	A	C	122	PASS	AN=2;DP=65	GT	0/1
chr5	840661	840661	A	G	exonic	ZDHHC11	.	nonsynonymous SNV	ZDHHC11:NM_024786:exon5:c.T733C:p.F245L	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	1.0	0.108	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	N	0.09	0.084	N	1.96	0.386	T	1.6	0.332	N	0.468	0.519	-1.058	0.123	T	0.035	0.151	T	0.001	0.012	T	-3.140	0.001	0.001	0.082	0.001	0.002	0.011	N	c	-2.141	-2.214	0.998	0.363	0.696	0.567	0	-5.47	0.024	-0.923	0.041	-1.725	0.007	0.000	0.063	0.000	0.016	3.145	0.060	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	124	266	chr5	840661	chr5:840661	A	G	124	PASS	AN=2;DP=266	GT	0/1
chr5	32419849	32419849	T	C	intronic	ZFR	.	.	.	0.99999967	3.30E-07	7.06E-18	.	0.63808	0.14804	-0.754958418	13.57631517	2316.48591	8.91305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	50	chr5	32419849	chr5:32419849	T	C	52	PASS	AN=2;DP=50	GT	0/1
chr5	98860073	98860073	G	C	intergenic	LOC100289230;LINC02113	dist=593360;dist=9621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	186	chr5	98860073	chr5:98860073	G	C	93	PASS	AN=2;DP=186	GT	0/1
chr5	140590171	140590171	G	T	exonic	PCDHB12	.	synonymous SNV	PCDHB12:NM_018932:exon1:c.G1692T:p.P564P	0.000155402	0.669826242	0.330018356	.	0.04439	.	2.476806522	98.62585515	2834.29925	10.05542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	627	chr5	140590171	chr5:140590171	G	T	98	PASS	AN=2;DP=627	GT	0/1
chr6	26860522	26860522	C	T	ncRNA_intronic	GUSBP2	.	.	.	.	.	.	.	0.09983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	77	chr6	26860522	chr6:26860522	C	T	58	PASS	AN=2;DP=77	GT	0/1
chr6	26864789	26864789	A	G	ncRNA_intronic	GUSBP2	.	.	.	.	.	.	.	0.09983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	334	chr6	26864789	chr6:26864789	A	G	100	PASS	AN=2;DP=334	GT	0/1
chr6	118320463	118320463	T	G	intronic	SLC35F1	.	.	.	0.38850627	0.611072726	0.000421004	.	0.29195	0.10809	0.060756528	58.52795471	23.09728	0.77064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	176	chr6	118320463	chr6:118320463	T	G	91	PASS	AN=2;DP=176	GT	0/1
chr6	150211100	150211100	T	C	exonic	RAET1E	.	synonymous SNV	RAET1E:NM_001243325:exon2:c.A159G:p.E53E,RAET1E:NM_001243327:exon2:c.A267G:p.E89E,RAET1E:NM_139165:exon2:c.A267G:p.E89E,RAET1E:NM_001243328:exon3:c.A267G:p.E89E	1.86E-05	0.454025759	0.545955646	.	0.03332	0.12047	2.149758993	97.97711724	1343.90882	6.88288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	100	chr6	150211100	chr6:150211100	T	C	65	PASS	AN=2;DP=100	GT	0/1
chr6	151266564	151266564	T	C	intronic	MTHFD1L	.	.	.	0.082519529	0.917479751	7.19E-07	.	0.08466	0.26137	-0.350843407	29.54116537	277.38146	3.56775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	66	chr6	151266564	chr6:151266564	T	C	60	PASS	AN=2;DP=66	GT	0/1
chr6	159670100	159670100	A	G	exonic	FNDC1	.	nonsynonymous SNV	FNDC1:NM_032532:exon16:c.A4720G:p.T1574A	3.07E-07	0.999968249	3.14E-05	.	0.1324	0.09503	2.671889479	98.84996461	6512.79761	16.93629	0.042	0.416	D	0.15	0.264	B	0.066	0.260	B	0.264	0.153	N	0.227	0.342	P	0.17	0.090	N	3.04	0.088	T	0.15	0.053	N	0.022	0.214	-0.917	0.460	T	0.005	0.015	T	.	.	.	0.592	0.151	8.100	0.783	0.118	0.015	0.050	N	c	-1.004	-1.009	1.000	0.454	0.487	0.133	0	-3.14	0.049	-0.991	0.038	-1.017	0.021	0.000	0.063	0.012	0.117	4.383	0.107	.	.	.	0.5	147	71	chr6	159670100	chr6:159670100	A	G	147	PASS	AN=2;DP=71	GT	0/1
chr7	2702316	2702316	C	T	UTR3	TTYH3	NM_025250:c.*943C>T	.	.	0.979598759	0.02039783	3.41E-06	.	0.20673	0.13236	-0.354480518	29.42911064	106.07775	2.23473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	387	chr7	2702316	chr7:2702316	C	T	90	PASS	AN=2;DP=387	GT	0/1
chr7	56881152	56881152	A	G	upstream	LOC401357	dist=723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	1650	chr7	56881152	chr7:56881152	A	G	164	PASS	AN=2;DP=1650	GT	0/1
chr7	65257835	65257835	C	G	intergenic	LOC441242;VKORC1L1	dist=22038;dist=80251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	207	295	chr7	65257835	chr7:65257835	C	G	207	PASS	AN=2;DP=295	GT	0/1
chr7	72712404	72712404	G	A	intergenic	NCF1B;NSUN5	dist=62425;dist=4109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	311	chr7	72712404	chr7:72712404	G	A	118	PASS	AN=2;DP=311	GT	0/1
chr7	76135134	76135134	G	A	UTR3	DTX2	NM_020892:c.*216G>A;NM_001102594:c.*216G>A;NM_001102595:c.*216G>A;NM_001102596:c.*216G>A	.	.	0.106757916	0.886582047	0.006660037	.	0.25831	0.10988	-0.683363435	15.36329323	137.65609	2.55415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	376	chr7	76135134	chr7:76135134	G	A	96	PASS	AN=2;DP=376	GT	0/1
chr7	95025600	95025600	G	A	exonic	PON3	.	synonymous SNV	PON3:NM_000940:exon1:c.C63T:p.F21F	0.002536783	0.931423061	0.066040156	.	0.10846	0.11133	0.64123826	83.97617363	216.51685	3.17966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	238	chr7	95025600	chr7:95025600	G	A	82	PASS	AN=2;DP=238	GT	0/1
chr7	98602990	98602990	G	C	intronic	TRRAP	.	.	.	1	1.50E-21	1.65E-53	DISEASE: Note=TRRAP mutation Phe-722 has been frequently found in cutaneous malignant melanoma, suggesting that TRRAP may play a role in the pathogenesis of melanoma. {ECO:0000269|PubMed:21499247}.; 	0.90101	0.52705	-6.141724508	0.035385704	221.99559	3.22188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	114	chr7	98602990	chr7:98602990	G	C	75	PASS	AN=2;DP=114	GT	0/1
chr7	98857825	98857825	C	T	intergenic	KPNA7;MYH16	dist=52713;dist=13099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	224	chr7	98857825	chr7:98857825	C	T	79	PASS	AN=2;DP=224	GT	0/1
chr7	100552044	100552044	T	G	exonic	MUC3A	.	synonymous SNV	MUC3A:NM_005960:exon4:c.T2625G:p.S875S	.	.	.	.	.	.	.	.	4720.00036	13.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	101	chr7	100552044	chr7:100552044	T	G	145	PASS	AN=2;DP=101	GT	0/1
chr7	100683067	100683067	C	T	exonic	MUC17	.	synonymous SNV	MUC17:NM_001040105:exon3:c.C8370T:p.S2790S	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	72	chr7	100683067	chr7:100683067	C	T	88	PASS	AN=2;DP=72	GT	0/1
chr7	107392911	107392911	C	G	intronic	CBLL1	.	.	.	0.997784848	0.002215079	7.36E-08	.	0.29297	0.11049	-0.516085732	21.20193442	14.90934	0.5368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	154	chr7	107392911	chr7:107392911	C	G	93	PASS	AN=2;DP=154	GT	0/1
chr7	124116470	124116470	A	G	intergenic	LOC101928211;GPR37	dist=124320;dist=269185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	174	chr7	124116470	chr7:124116470	A	G	80	PASS	AN=2;DP=174	GT	0/1
chr7	151935853	151935853	T	C	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.077	0.346	T	0.986	0.596	D	0.655	0.508	P	0.010	0.301	N	1.000	0.488	D	1.95	0.526	M	-2.06	0.860	D	-1.73	0.410	N	0.593	0.620	-0.013	0.820	T	0.585	0.851	D	.	.	.	4.196	0.562	23.9	0.998	0.907	0.978	0.770	D	c	0.478	0.540	1.000	0.747	0.651	0.465	0	5.53	0.825	7.411	0.791	1.061	0.807	1.000	0.715	1.000	0.888	15.955	0.796	.	.	.	0.5	95	120	chr7	151935853	chr7:151935853	T	C	95	PASS	AN=2;DP=120	GT	0/1
chr7	151962290	151962290	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon8:c.G1017C:p.K339N	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.246	0.173	T	0.999	0.764	D	0.991	0.782	D	0.001	0.432	U	0.938	0.372	D	1.445	0.365	L	-5.16	0.988	D	-2.17	0.490	N	0.153	0.189	0.881	0.954	D	0.928	0.976	D	.	.	.	2.356	0.344	18.53	0.986	0.425	0.867	0.457	D	c	-0.067	-0.115	0.503	0.209	0.707	0.730	0	3.77	0.423	1.960	0.398	0.802	0.324	1.000	0.715	0.997	0.653	11.249	0.481	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Zinc finger, FYVE/PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	74	126	chr7	151962290	chr7:151962290	C	G	74	PASS	AN=2;DP=126	GT	0/1
chr8	7217837	7217837	A	C	exonic	ZNF705G	.	nonsynonymous SNV	ZNF705G:NM_001164457:exon3:c.T157G:p.S53A	4.25E-09	0.029374202	0.970625794	.	.	.	.	.	148.15733	2.652	0.989	0.020	T	.	.	.	.	.	.	.	.	.	1	0.090	P	1.21	0.306	L	5.67	0.008	T	-0.81	0.223	N	0.063	0.052	-0.934	0.436	T	0.003	0.010	T	.	.	.	0.711	0.162	8.899	0.689	0.085	0.152	0.186	N	c	-0.796	-0.967	0.000	0.038	0.549	0.223	0	-0.55	0.112	0.991	0.291	0.493	0.279	0.948	0.327	0.012	0.117	2.993	0.056	Krueppel-associated box	.	.	0.5	118	65	chr8	7217837	chr8:7217837	A	C	118	PASS	AN=2;DP=65	GT	0/1
chr8	12040158	12040158	A	G	UTR3	FAM86B1	NM_001083537:c.*957T>C	.	.	0.744460341	0.244896121	0.010643538	.	.	.	.	.	492.38443	4.56268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	143	chr8	12040158	chr8:12040158	A	G	99	PASS	AN=2;DP=143	GT	0/1
chr8	12522853	12522861	GTCCTCGCA	-	ncRNA_exonic	LOC729732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	160	290	chr8	12522852	chr8:12522852	CGTCCTCGCA	C	160	PASS	AN=2;DP=290	GT	0/1
chr9	38603140	38603140	-	T	intronic	ANKRD18A	.	.	.	0.000945591	0.578001567	0.421052842	.	0.01878	.	2.704844505	98.90894079	4407.02172	13.26594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	34	chr9	38603140	chr9:38603140	A	AT	83	PASS	AN=2;DP=34	GT	0/1
chr9	66457161	66457161	A	G	upstream	LINC01410	dist=128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	102	chr9	66457161	chr9:66457161	A	G	82	PASS	AN=2;DP=102	GT	0/1
chr9	90746211	90746211	T	C	exonic	SPATA31C2	.	nonsynonymous SNV	SPATA31C2:NM_001166137:exon4:c.A1741G:p.S581G,SPATA31C2:NM_001350978:exon4:c.A1741G:p.S581G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	105	chr9	90746211	chr9:90746211	T	C	118	PASS	AN=2;DP=105	GT	0/1
chr9	129453229	129453229	A	G	exonic	LMX1B	.	synonymous SNV	LMX1B:NM_001174146:exon3:c.A441G:p.E147E,LMX1B:NM_001174147:exon3:c.A441G:p.E147E,LMX1B:NM_002316:exon3:c.A441G:p.E147E	0.82273227	0.177096322	0.000171408	.	0.35834	0.35026	-0.846787714	11.05803255	23.27331	0.77647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	235	chr9	129453229	chr9:129453229	A	G	102	PASS	AN=2;DP=235	GT	0/1
chr9	140686492	140686492	-	T	intronic	EHMT1	.	.	.	0.999999904	9.60E-08	3.49E-19	DISEASE: Kleefstra syndrome (KLESTS) [MIM:610253]: A syndrome characterized by severe mental retardation, hypotonia, brachy(micro)cephaly, and facial dysmorphisms. Additionally, congenital heart defects, urogenital defects, epilepsy and behavioral problems are frequently observed. {ECO:0000269|PubMed:16826528, ECO:0000269|PubMed:19264732}. Note=The disease is caused by mutations affecting the gene represented in this entry (PubMed:16826528). The syndrome can be either caused by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene or by a submicroscopic 9q34.3 deletion. Although it is not known if and to what extent other genes in the 9q34.3 region contribute to the syndrome observed in deletion cases, EHMT1 seems to be the major determinant of the core disease phenotype (PubMed:19264732). {ECO:0000269|PubMed:16826528, ECO:0000269|PubMed:19264732}.; 	0.19698	0.1459	-1.582005788	3.13163482	397.32742	4.1876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	117	chr9	140686492	chr9:140686492	C	CT	89	PASS	AN=2;DP=117	GT	0/1
chr10	17271400	17271400	G	C	ncRNA_exonic	VIM-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	144	chr10	17271400	chr10:17271400	G	C	85	PASS	AN=2;DP=144	GT	0/1
chr10	49199763	49199763	T	C	intergenic	GLUD1P7;FAM25C	dist=219424;dist=3592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	399	chr10	49199763	chr10:49199763	T	C	92	PASS	AN=2;DP=399	GT	0/1
chr10	49199766	49199766	C	G	intergenic	GLUD1P7;FAM25C	dist=219427;dist=3589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	403	chr10	49199766	chr10:49199766	C	G	90	PASS	AN=2;DP=403	GT	0/1
chr10	124340406	124340406	G	C	exonic	DMBT1	.	nonsynonymous SNV	DMBT1:NM_001320644:exon11:c.G1028C:p.S343T,DMBT1:NM_004406:exon11:c.G1028C:p.S343T,DMBT1:NM_007329:exon11:c.G1028C:p.S343T,DMBT1:NM_017579:exon11:c.G1028C:p.S343T	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	0.674	0.079	T	0.007	0.365	B	0.005	0.288	B	.	.	.	1	0.090	N	0.345	0.112	N	1.89	0.250	T	0.2	0.172	N	0.058	0.213	-1.033	0.196	T	0.000	0.000	T	.	.	.	-3.190	0.001	0.001	0.121	0.002	0.000	0.004	N	c	-1.974	-2.081	0.937	0.272	0.487	0.133	0	-2.67	0.057	-4.937	0.002	-0.216	0.099	0.000	0.063	0.000	0.016	5.712	0.171	.	.	.	0.5	113	324	chr10	124340406	chr10:124340406	G	C	113	PASS	AN=2;DP=324	GT	0/1
chr10	129903465	129903465	A	G	exonic	MKI67	.	synonymous SNV	MKI67:NM_001145966:exon12:c.T5559C:p.H1853H,MKI67:NM_002417:exon13:c.T6639C:p.H2213H	4.17E-16	0.998663439	0.001336561	.	0.62381	.	7.633856952	99.91153574	13447.4791	25.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	116	chr10	129903465	chr10:129903465	A	G	90	PASS	AN=2;DP=116	GT	0/1
chr10	135000148	135000148	T	C	exonic	KNDC1	.	synonymous SNV	KNDC1:NM_152643:exon6:c.T1296C:p.A432A	4.44E-05	0.999952561	3.01E-06	.	0.11621	0.09546	1.089385192	91.85539042	1045.18642	6.20522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	253	chr10	135000148	chr10:135000148	T	C	88	PASS	AN=2;DP=253	GT	0/1
chr11	1309956	1309956	C	T	exonic	TOLLIP	.	synonymous SNV	TOLLIP:NM_001318512:exon3:c.G267A:p.P89P,TOLLIP:NM_001318516:exon3:c.G234A:p.P78P,TOLLIP:NM_001318514:exon4:c.G210A:p.P70P,TOLLIP:NM_019009:exon4:c.G417A:p.P139P	0.522906268	0.473487996	0.003605736	.	0.16248	0.14352	-0.468351206	23.42533616	235.45459	3.31615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	217	chr11	1309956	chr11:1309956	C	T	103	PASS	AN=2;DP=217	GT	0/1
chr11	3578576	3578576	G	T	ncRNA_intronic	LOC101927708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	93	chr11	3578576	chr11:3578576	G	T	123	PASS	AN=2;DP=93	GT	0/1
chr11	6499215	6499215	A	G	intronic	ARFIP2	.	.	.	0.94293271	0.057023224	4.41E-05	.	0.14975	0.14609	-0.427900189	25.14744043	14.33009	0.51775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	88	chr11	6499215	chr11:6499215	A	G	77	PASS	AN=2;DP=88	GT	0/1
chr11	123598941	123598941	T	C	exonic	ZNF202	.	synonymous SNV	ZNF202:NM_001301819:exon4:c.A60G:p.V20V,ZNF202:NM_001301780:exon5:c.A732G:p.V244V,ZNF202:NM_001301779:exon6:c.A732G:p.V244V,ZNF202:NM_003455:exon7:c.A732G:p.V244V	0.138743298	0.86039682	0.000859882	.	0.14654	0.1493	-0.200157416	39.11299835	48.89763	1.36475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	78	chr11	123598941	chr11:123598941	T	C	66	PASS	AN=2;DP=78	GT	0/1
chr11	124086220	124086220	A	G	intergenic	VWA5A;OR8G2P	dist=68602;dist=9124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	111	chr11	124086220	chr11:124086220	A	G	88	PASS	AN=2;DP=111	GT	0/1
chr11	124767067	124767067	T	C	exonic	ROBO4	.	nonsynonymous SNV	ROBO4:NM_019055:exon2:c.A161G:p.Q54R	1.67E-09	0.950296357	0.049703642	.	0.09052	0.12945	0.657639543	84.20028309	3167.49955	10.73314	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.292	0.147	N	1	0.228	P	-0.485	0.027	N	-0.25	0.670	T	1.4	0.008	N	0.022	0.007	-0.933	0.438	T	0.000	0.000	T	.	.	.	-0.531	0.054	0.184	0.788	0.120	0.011	0.041	N	c	-1.108	-1.025	1.000	0.747	0.628	0.401	0	0.134	0.140	-0.495	0.065	0.016	0.142	0.000	0.063	0.883	0.370	10.126	0.416	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	ENSG00000254568.1|ENSG00000154133.10|ENSG00000154134.10|ENSG00000154134.10|ENSG00000154134.10|ENSG00000203306.3|ENSG00000154134.10|ENSG00000154134.10	Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid	0.5	67	133	chr11	124767067	chr11:124767067	T	C	67	PASS	AN=2;DP=133	GT	0/1
chr12	7864192	7864192	C	T	exonic	DPPA3	.	nonsynonymous SNV	DPPA3:NM_199286:exon1:c.C26T:p.T9I	0.165194336	0.772640391	0.062165272	.	0.02429	0.07229	0.591694063	82.45458835	39.72884	1.1709	0.021	0.491	D	0.999	0.764	D	0.964	0.693	D	.	.	.	1	0.090	N	1.995	0.543	M	0.81	0.485	T	-3.58	0.691	D	0.194	0.238	-1.003	0.291	T	0.154	0.484	T	0.003	0.070	T	3.077	0.430	22.5	0.977	0.349	0.032	0.082	N	c	-0.473	-0.689	0.000	0.035	0.487	0.133	0	1.91	0.247	0.624	0.240	-0.042	0.124	0.003	0.159	0.002	0.062	7.119	0.245	.	.	.	0.5	67	106	chr12	7864192	chr12:7864192	C	T	67	PASS	AN=2;DP=106	GT	0/1
chr12	8082367	8082367	T	C	exonic	SLC2A3	.	synonymous SNV	SLC2A3:NM_006931:exon6:c.A774G:p.L258L	0.519822946	0.47941858	0.000758474	.	0.35764	0.14971	0.619191319	83.36282142	55.14143	1.4881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	113	chr12	8082367	chr12:8082367	T	C	90	PASS	AN=2;DP=113	GT	0/1
chr12	52886478	52886478	T	C	exonic	KRT6A	.	synonymous SNV	KRT6A:NM_005554:exon1:c.A495G:p.E165E	0.948763036	0.051203361	3.36E-05	.	0.31132	0.27311	0.714657953	85.81623024	2798.4726	9.98404	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	255	chr12	52886478	chr12:52886478	T	C	123	PASS	AN=2;DP=255	GT	0/1
chr12	122672313	122672313	C	T	exonic	LRRC43	.	synonymous SNV	LRRC43:NM_001098519:exon4:c.C588T:p.G196G,LRRC43:NM_152759:exon4:c.C33T:p.G11G	6.70E-14	0.015985486	0.984014514	.	0.05087	.	0.404185162	76.48619958	2151.99418	8.53257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	221	chr12	122672313	chr12:122672313	C	T	83	PASS	AN=2;DP=221	GT	0/1
chr13	19393386	19393386	C	T	ncRNA_exonic	ANKRD20A9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	116	chr13	19393386	chr13:19393386	C	T	104	PASS	AN=2;DP=116	GT	0/1
chr13	25161438	25161438	T	A	ncRNA_exonic	TPTE2P6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	117	chr13	25161438	chr13:25161438	T	A	141	PASS	AN=2;DP=117	GT	0/1
chr13	111164469	111164469	C	T	exonic	COL4A2	.	synonymous SNV	COL4A2:NM_001846:exon48:c.C5070T:p.A1690A	2.11E-06	0.999997874	1.64E-08	DISEASE: Porencephaly 2 (POREN2) [MIM:614483]: A neurologic disorder characterized by a fluid-filled cysts or cavities within the cerebral hemispheres. Affected individuals typically have hemiplegia, seizures, and intellectual disability. Porencephaly type 2, or schizencephalic porencephaly, is usually symmetric and represents a primary defect in the development of the cerebral ventricles. {ECO:0000269|PubMed:22209246}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intracerebral hemorrhage (ICH) [MIM:614519]: A pathological condition characterized by bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. Intracerebral bleeding is a common cause of stroke. {ECO:0000269|PubMed:22209247}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.26795	.	-0.643198486	16.53102147	2430.98324	9.15844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	256	chr13	111164469	chr13:111164469	C	T	88	PASS	AN=2;DP=256	GT	0/1
chr13	113534907	113534907	T	C	intronic	ATP11A	.	.	.	0.967333743	0.032666257	3.07E-11	.	0.22056	0.10642	-1.605857744	3.007784855	269.18999	3.51905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	417	chr13	113534907	chr13:113534907	T	C	97	PASS	AN=2;DP=417	GT	0/1
chr14	19806550	19806550	A	T	intergenic	DUXAP10;LINC01296	dist=113634;dist=73659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	343	chr14	19806550	chr14:19806550	A	T	139	PASS	AN=2;DP=343	GT	0/1
chr14	19807147	19807147	A	C	intergenic	DUXAP10;LINC01296	dist=114231;dist=73062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	218	chr14	19807147	chr14:19807147	A	C	149	PASS	AN=2;DP=218	GT	0/1
chr14	22974041	22974041	T	G	intergenic	OR4E1;LINC02332	dist=834809;dist=51164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	95	chr14	22974041	chr14:22974041	T	G	72	PASS	AN=2;DP=95	GT	0/1
chr14	23792215	23792215	G	A	exonic	BCL2L2-PABPN1;PABPN1	.	synonymous SNV	PABPN1:NM_004643:exon3:c.G474A:p.P158P,BCL2L2-PABPN1:NM_001199864:exon5:c.G555A:p.P185P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	97	chr14	23792215	chr14:23792215	G	A	67	PASS	AN=2;DP=97	GT	0/1
chr14	23852497	23852497	T	C	exonic	MYH6	.	synonymous SNV	MYH6:NM_002471:exon37:c.A5598G:p.L1866L	1.28E-17	0.998347117	0.001652883	DISEASE: Atrial septal defect 3 (ASD3) [MIM:614089]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:15735645}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 14 (CMH14) [MIM:613251]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sick sinus syndrome 3 (SSS3) [MIM:614090]: The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors. {ECO:0000269|PubMed:21378987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. The lifetime risk of being diagnosed with sick sinus syndrome is higher for carriers of variant p.Arg721Trp than for non-carriers. {ECO:0000269|PubMed:21378987}.; 	0.84563	0.11625	-2.784931854	0.660533145	5098.77916	14.63955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	209	chr14	23852497	chr14:23852497	T	C	87	PASS	AN=2;DP=209	GT	0/1
chr14	35409214	35409214	T	C	ncRNA_exonic	IGBP1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	92	chr14	35409214	chr14:35409214	T	C	90	PASS	AN=2;DP=92	GT	0/1
chr14	66479768	66479768	A	C	intergenic	FUT8;CCDC196	dist=268929;dist=473321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	126	chr14	66479768	chr14:66479768	A	C	71	PASS	AN=2;DP=126	GT	0/1
chr14	104563874	104563874	C	T	intronic	ASPG	.	.	.	1.18E-06	0.576666352	0.423332466	.	.	0.11691	0.560331224	81.70559094	4760.58672	13.97008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	225	chr14	104563874	chr14:104563874	C	T	82	PASS	AN=2;DP=225	GT	0/1
chr14	105196230	105196230	A	C	exonic	ADSSL1	.	nonsynonymous SNV	ADSSL1:NM_199165:exon1:c.A1C:p.M1L	0.000383323	0.990043419	0.009573258	.	0.25728	0.15503	-0.020150552	52.25288983	212.40167	3.1447	0.072	0.349	T	0.003	0.102	B	0.0	0.013	B	.	.	.	0.000	0.810	P	.	.	.	1.09	0.392	T	0.1	0.058	N	0.026	0.008	-0.939	0.429	T	0.000	0.000	T	.	.	.	-1.742	0.012	0.002	0.594	0.061	0.011	0.040	N	c	-1.464	-1.611	1.000	0.747	0.403	0.052	0	-0.317	0.120	-1.196	0.031	-1.937	0.005	0.040	0.208	0.001	0.043	.	.	.	ENSG00000184990.8|ENSG00000184990.8|ENSG00000185100.6|ENSG00000185100.6|ENSG00000184990.8|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000258430.1|ENSG00000179627.9|ENSG00000142208.11	Artery_Aorta|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Thyroid|Thyroid	0.5	159	140	chr14	105196230	chr14:105196230	A	C	159	PASS	AN=2;DP=140	GT	0/1
chr14	105409907	105409907	T	C	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.A11581G:p.M3861V,AHNAK2:NM_138420:exon7:c.A11881G:p.M3961V	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.821	0.029	T	0.001	0.067	B	0.002	0.063	B	.	.	.	1	0.090	P	-1.81	0.003	N	5.91	0.007	T	0.82	0.018	N	0.029	0.010	-1.031	0.201	T	0.000	0.000	T	.	.	.	-2.862	0.002	0.001	0.314	0.018	0.001	0.009	N	c	-2.060	-1.979	0.000	0.053	0.707	0.730	0	-1.33	0.086	-2.756	0.009	-2.887	0.002	0.000	0.063	0.000	0.016	5.609	0.166	.	ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000185567.6|ENSG00000140104.9	Adipose_Subcutaneous|Adrenal_Gland|Artery_Tibial|Brain_Cerebellum|Brain_Cortex|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Esophagus_Muscularis|Skin_Sun_Exposed_Lower_leg	0.5	90	352	chr14	105409907	chr14:105409907	T	C	90	PASS	AN=2;DP=352	GT	0/1
chr14	106518848	106518848	T	C	intergenic	ADAM6;LINC00226	dist=80490;dist=225421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	102	chr14	106518848	chr14:106518848	T	C	99	PASS	AN=2;DP=102	GT	0/1
chr14	106573251	106573251	G	A	intergenic	ADAM6;LINC00226	dist=134893;dist=171018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	132	chr14	106573251	chr14:106573251	G	A	130	PASS	AN=2;DP=132	GT	0/1
chr15	20446047	20446047	T	G	intergenic	NONE;CHEK2P2	dist=NONE;dist=41950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	95	chr15	20446047	chr15:20446047	T	G	67	PASS	AN=2;DP=95	GT	0/1
chr15	20457244	20457244	G	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=30753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	167	chr15	20457244	chr15:20457244	G	C	85	PASS	AN=2;DP=167	GT	0/1
chr15	25451471	25451471	A	G	ncRNA_exonic	SNORD115-20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	70	chr15	25451471	chr15:25451471	A	G	70	PASS	AN=2;DP=70	GT	0/1
chr15	34812832	34812832	C	T	intergenic	NONE;GOLGA8B	dist=NONE;dist=4652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	297	chr15	34812832	chr15:34812832	C	T	113	PASS	AN=2;DP=297	GT	0/1
chr15	49117125	49117125	-	T	UTR3	SHC4	NM_203349:c.*1042_*1043insA	.	.	1.17E-05	0.988149866	0.011838437	.	0.29902	0.12806	-0.709045403	14.673272	251.32202	3.41544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	19	chr15	49117125	chr15:49117125	G	GT	98	PASS	AN=2;DP=19	GT	1/0
chr15	81281900	81281900	G	A	intronic	MESD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	198	chr15	81281900	chr15:81281900	G	A	87	PASS	AN=2;DP=198	GT	0/1
chr15	84945512	84945512	C	T	intergenic	GOLGA6L4;LOC103171574	dist=31392;dist=31705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	159	chr15	84945512	chr15:84945512	C	T	82	PASS	AN=2;DP=159	GT	0/1
chr15	89421327	89421327	A	G	exonic	HAPLN3	.	synonymous SNV	HAPLN3:NM_178232:exon5:c.T957C:p.G319G,HAPLN3:NM_001307952:exon6:c.T1143C:p.G381G	3.92E-06	0.370376544	0.629619539	.	0.1436	0.10628	-0.354480518	29.42911064	4444.58352	13.35637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	206	250	chr15	89421327	chr15:89421327	A	G	206	PASS	AN=2;DP=250	GT	1/0
chr15	100331824	100331824	A	C	ncRNA_exonic	DNM1P46	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	321	chr15	100331824	chr15:100331824	A	C	102	PASS	AN=2;DP=321	GT	0/1
chr15	100821467	100821467	G	A	exonic	ADAMTS17	.	synonymous SNV	ADAMTS17:NM_139057:exon4:c.C756T:p.A252A	3.83E-11	0.995733613	0.004266387	DISEASE: Weill-Marchesani-like syndrome (WMLS) [MIM:613195]: A disorder characterized by many of the key features of Weill- Marchesani syndrome, including lenticular myopia, ectopia lentis, glaucoma, spherophakia and short stature. However, the characteristic brachydactyly or decreased joint flexibility of Weill-Marchesani syndrome are absent. {ECO:0000269|PubMed:19836009}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24727	0.12398	-2.267592656	1.262090116	3746.43136	11.97553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	432	chr15	100821467	chr15:100821467	G	A	112	PASS	AN=2;DP=432	GT	0/1
chr15	102515257	102515257	C	T	ncRNA_exonic	WASH3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	1098	chr15	102515257	chr15:102515257	C	T	168	PASS	AN=2;DP=1098	GT	0/1
chr16	74287	74287	C	G	ncRNA_exonic	WASIR2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	885	chr16	74287	chr16:74287	C	G	153	PASS	AN=2;DP=885	GT	0/1
chr16	2009697	2009697	C	T	exonic	NDUFB10	.	synonymous SNV	NDUFB10:NM_004548:exon1:c.C72T:p.I24I	0.046629914	0.854526808	0.098843278	.	0.06368	0.09902	-0.471992905	23.03609342	20.73017	0.70328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	175	253	chr16	2009697	chr16:2009697	C	T	175	PASS	AN=2;DP=253	GT	0/1
chr16	12371915	12371915	T	C	intronic	SNX29	.	.	.	1.78E-06	0.992709756	0.007288459	.	0.22646	.	-0.556537043	19.72753008	208.69672	3.11731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	90	chr16	12371915	chr16:12371915	T	C	71	PASS	AN=2;DP=90	GT	0/1
chr16	14013993	14013993	T	A	upstream	ERCC4	dist=21	.	.	3.33E-10	0.733032262	0.266967737	DISEASE: Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. XP-F patients show a mild phenotype. {ECO:0000269|PubMed:8797827, ECO:0000269|PubMed:9579555, ECO:0000269|PubMed:9580660}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: XFE progeroid syndrome (XFEPS) [MIM:610965]: A syndrome characterized by aged bird-like facies, lack of subcutaneous fat, dwarfism, cachexia and microcephaly. Additional features include sun-sensitivity from birth, learning disabilities, hearing loss, and visual impairment. {ECO:0000269|PubMed:17183314}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Xeroderma pigmentosum type F/Cockayne syndrome (XPF/CS) [MIM:278760]: A variant form of Cockayne syndrome, a disorder characterized by growth retardation, microcephaly, impairment of nervous system development, pigmentary retinopathy, peculiar facies, and progeria together with abnormal skin photosensitivity. Cockayne syndrome dermatological features are milder than those in xeroderma pigmentosum and skin cancers are not found in affected individuals. XPF/CS patients, however, present with severe skin phenotypes, including severe photosensitivity, abnormal skin pigmentation, and skin cancer predisposition. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group Q (FANCQ) [MIM:615272]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:23623386, ECO:0000269|PubMed:24027083}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.8426	0.47836	-0.367438677	28.29087049	549.8051	4.76877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	483	chr16	14013993	chr16:14013993	T	A	100	PASS	AN=2;DP=483	GT	0/1
chr16	15223599	15223599	G	A	ncRNA_intronic	PKD1P6-NPIPP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	267	chr16	15223599	chr16:15223599	G	A	93	PASS	AN=2;DP=267	GT	0/1
chr16	16457549	16457549	C	T	ncRNA_intronic	PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	574	chr16	16457549	chr16:16457549	C	T	164	PASS	AN=2;DP=574	GT	0/1
chr16	28618446	28618446	T	C	intronic	SULT1A1	.	.	.	2.24E-09	0.073319455	0.926680543	.	0.09968	0.40709	-0.156065314	42.16206653	63.72574	1.63669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	179	238	chr16	28618446	chr16:28618446	T	C	179	PASS	AN=2;DP=238	GT	0/1
chr16	69988359	69988359	A	G	exonic	CLEC18A	.	synonymous SNV	CLEC18A:NM_001136214:exon4:c.A339G:p.L113L,CLEC18A:NM_001271197:exon4:c.A339G:p.L113L,CLEC18A:NM_182619:exon4:c.A339G:p.L113L	0.144113695	0.778785582	0.077100722	.	.	.	.	.	3437.51904	11.25783	.	.	.	.	.	.	.	.	.	.	.	.	0.000	0.588	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.764	0.167	9.239	0.305	0.017	0.026	0.071	N	c	-0.605	-0.680	0.001	0.080	0.554	0.246	0	1.97	0.252	0.164	0.162	-0.026	0.128	0.993	0.376	0.084	0.183	4.761	0.124	.	ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000223496.1|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000223496.1|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000196696.8|ENSG00000157335.15|ENSG00000157322.12|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157335.15|ENSG00000157322.12|ENSG00000157322.12|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000196696.8|ENSG00000157322.12|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Coronary|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Brain_Caudate_basal_ganglia|Brain_Cerebellum|Brain_Cortex|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Heart_Left_Ventricle|Lung|Lung|Lung|Lung|Lung|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Ovary|Pancreas|Pancreas|Pancreas|Pancreas|Prostate|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Small_Intestine_Terminal_Ileum|Spleen|Spleen|Stomach|Stomach|Testis|Testis|Testis|Thyroid|Thyroid|Thyroid|Thyroid|Vagina|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood	0.5	146	234	chr16	69988359	chr16:69988359	A	G	146	PASS	AN=2;DP=234	GT	0/1
chr16	75267786	75267786	G	T	exonic	BCAR1	.	synonymous SNV	BCAR1:NM_001170721:exon5:c.C1428A:p.G476G,BCAR1:NM_001170715:exon6:c.C2112A:p.G704G,BCAR1:NM_001170716:exon6:c.C2112A:p.G704G,BCAR1:NM_001170717:exon6:c.C2112A:p.G704G,BCAR1:NM_001170718:exon6:c.C2058A:p.G686G,BCAR1:NM_001170719:exon6:c.C2052A:p.G684G,BCAR1:NM_014567:exon6:c.C2058A:p.G686G,BCAR1:NM_001170714:exon7:c.C2196A:p.G732G,BCAR1:NM_001170720:exon7:c.C1614A:p.G538G	0.992956578	0.007043171	2.51E-07	.	0.47335	.	1.53037684	95.51191319	778.41129	5.52069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	312	chr16	75267786	chr16:75267786	G	T	107	PASS	AN=2;DP=312	GT	0/1
chr16	78011559	78011559	C	T	exonic	VAT1L	.	synonymous SNV	VAT1L:NM_020927:exon9:c.C1227T:p.S409S	1.90E-05	0.696133091	0.30384793	.	.	0.13287	-0.290161348	33.33923095	120.82271	2.39555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	91	chr16	78011559	chr16:78011559	C	T	58	PASS	AN=2;DP=91	GT	0/1
chr16	89715671	89715671	T	C	intronic	CHMP1A	.	.	.	0.252036809	0.719472862	0.028490329	DISEASE: Pontocerebellar hypoplasia 8 (PCH8) [MIM:614961]: An autosomal recessive neurodevelopmental disorder characterized by severe psychomotor retardation, abnormal movements, hypotonia, spasticity, and variable visual defects. Brain MRI shows pontocerebellar hypoplasia, decreased cerebral white matter, and a thin corpus callosum. {ECO:0000269|PubMed:23023333}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08801	.	0.150760231	64.51403633	463.07131	4.4604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	149	chr16	89715671	chr16:89715671	T	C	84	PASS	AN=2;DP=149	GT	0/1
chr16	89715916	89715916	C	G	intronic	CHMP1A	.	.	.	0.252036809	0.719472862	0.028490329	DISEASE: Pontocerebellar hypoplasia 8 (PCH8) [MIM:614961]: An autosomal recessive neurodevelopmental disorder characterized by severe psychomotor retardation, abnormal movements, hypotonia, spasticity, and variable visual defects. Brain MRI shows pontocerebellar hypoplasia, decreased cerebral white matter, and a thin corpus callosum. {ECO:0000269|PubMed:23023333}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08801	.	0.150760231	64.51403633	463.07131	4.4604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	176	chr16	89715916	chr16:89715916	C	G	97	PASS	AN=2;DP=176	GT	0/1
chr17	1370542	1370542	C	A	exonic	MYO1C	.	synonymous SNV	MYO1C:NM_001080779:exon31:c.G3159T:p.L1053L,MYO1C:NM_001080950:exon31:c.G3102T:p.L1034L,MYO1C:NM_033375:exon31:c.G3054T:p.L1018L	3.89E-08	0.99997491	2.51E-05	.	0.24832	0.21196	-1.113491624	6.634819533	761.68047	5.47188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	410	chr17	1370542	chr17:1370542	C	A	150	PASS	AN=2;DP=410	GT	0/1
chr17	2995994	2995994	T	C	exonic	OR1D2	.	synonymous SNV	OR1D2:NM_002548:exon1:c.A297G:p.T99T	0.002382562	0.536721251	0.460896187	.	0.24373	0.0871	1.0178651	90.91766926	2083.61947	8.40767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	120	chr17	2995994	chr17:2995994	T	C	73	PASS	AN=2;DP=120	GT	0/1
chr17	11865150	11865150	C	T	intronic	DNAH9	.	.	.	1.37E-35	0.999999244	7.56E-07	.	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	48	chr17	11865150	chr17:11865150	C	T	58	PASS	AN=2;DP=48	GT	0/1
chr17	15496612	15496612	G	A	intronic	CDRT1	.	.	.	.	.	.	.	.	.	0.846940207	88.47605567	5108.29652	14.68503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	97	chr17	15496612	chr17:15496612	G	A	75	PASS	AN=2;DP=97	GT	0/1
chr17	15690863	15690863	T	A	ncRNA_exonic	MEIS3P1	.	.	.	.	.	.	.	0.18471	.	-0.134019284	43.90776126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	200	chr17	15690863	chr17:15690863	T	A	83	PASS	AN=2;DP=200	GT	0/1
chr17	19350020	19350049	CCGCGGCCTTGGCCCCGGCCCCGTCCACGG	-	intergenic	RNF112;SLC47A1	dist=29431;dist=87118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	158	222	chr17	19350019	chr17:19350019	TCCGCGGCCTTGGCCCCGGCCCCGTCCACGG	T	158	PASS	AN=2;DP=222	GT	0/1
chr17	27074223	27074223	C	A	intronic	TRAF4	.	.	.	0.840038712	0.159831706	0.000129581	.	0.35071	0.20238	-0.404032746	26.53338051	39.67284	1.16916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	188	chr17	27074223	chr17:27074223	C	A	117	PASS	AN=2;DP=188	GT	0/1
chr17	39240661	39240661	C	G	exonic	KRTAP4-7	.	nonsynonymous SNV	KRTAP4-7:NM_033061:exon1:c.C203G:p.T68S	1.11E-05	0.110363647	0.889625229	.	.	.	0.323496558	72.93583392	3093.65412	10.57314	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.001	0.006	N	1	0.090	P	.	.	.	5.16	0.012	T	1.18	0.011	N	0.065	0.051	-1.010	0.271	T	0.000	0.000	T	.	.	.	-2.048	0.007	0.001	0.571	0.056	0.001	0.004	N	c	-1.535	-1.629	0.008	0.116	0.487	0.133	0	-3.84	0.040	-2.458	0.011	-0.537	0.048	0.000	0.063	0.008	0.104	3.948	0.088	.	ENSG00000204880.6|ENSG00000198090.3	Esophagus_Mucosa|Whole_Blood	0.5	109	424	chr17	39240661	chr17:39240661	C	G	109	PASS	AN=2;DP=424	GT	0/1
chr17	39261933	39261933	C	T	exonic	KRTAP4-9	.	nonsynonymous SNV	KRTAP4-9:NM_001146041:exon1:c.C293T:p.A98V	0.001503782	0.44209467	0.556401547	.	0.16136	.	0.812172405	87.75654636	1745.942	7.71103	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.005	U	1	0.090	P	-2.06	0.002	N	1.49	0.315	T	0.72	0.021	N	0.126	0.143	-0.991	0.325	T	0.022	0.093	T	.	.	.	-0.559	0.052	0.158	0.635	0.070	0.002	0.013	N	c	-2.041	-2.030	0.009	0.118	0.447	0.083	0	-2.04	0.069	-4.879	0.002	-2.760	0.002	0.000	0.063	0.000	0.016	5.086	0.139	.	.	.	0.5	106	473	chr17	39261933	chr17:39261933	C	T	106	PASS	AN=2;DP=473	GT	0/1
chr17	39594980	39594980	C	T	exonic	KRT38	.	nonsynonymous SNV	KRT38:NM_006771:exon4:c.G863A:p.R288H	2.17E-05	0.724250939	0.275727343	.	0.08393	0.1123	-0.33061537	30.82094834	172.03352	2.86058	0.061	0.371	T	0.083	0.232	B	0.016	0.166	B	0.094	0.202	N	0.995	0.233	N	1.82	0.479	L	-2.6	0.899	D	-4.0	0.740	D	0.167	0.202	-0.436	0.709	T	0.381	0.738	T	.	.	.	4.125	0.553	23.8	0.981	0.374	0.200	0.207	N	c	-0.665	-0.734	0.000	0.071	0.497	0.185	0	-0.39	0.118	-0.681	0.053	0.077	0.185	0.000	0.063	0.540	0.278	4.993	0.135	.	.	.	0.5	76	171	chr17	39594980	chr17:39594980	C	T	76	PASS	AN=2;DP=171	GT	0/1
chr17	39595539	39595539	A	G	exonic	KRT38	.	synonymous SNV	KRT38:NM_006771:exon3:c.T648C:p.D216D	2.17E-05	0.724250939	0.275727343	.	0.08393	0.1123	-0.33061537	30.82094834	172.03352	2.86058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	333	chr17	39595539	chr17:39595539	A	G	133	PASS	AN=2;DP=333	GT	0/1
chr17	44117135	44117135	C	T	exonic	KANSL1	.	synonymous SNV	KANSL1:NM_001193466:exon8:c.G2136A:p.P712P,KANSL1:NM_015443:exon8:c.G2136A:p.P712P,KANSL1:NM_001193465:exon9:c.G2136A:p.P712P	0.999733506	0.000266494	3.49E-12	.	0.60193	0.13678	-0.321528174	30.95069592	5743.08683	15.71165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	131	chr17	44117135	chr17:44117135	C	T	88	PASS	AN=2;DP=131	GT	0/1
chr17	66124328	66124328	C	T	ncRNA_exonic	LINC00674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	108	chr17	66124328	chr17:66124328	C	T	81	PASS	AN=2;DP=108	GT	0/1
chr17	72949146	72949146	C	T	exonic	HID1	.	synonymous SNV	HID1:NM_030630:exon16:c.G2007A:p.P669P	0.46550532	0.534447268	4.74E-05	.	0.15824	0.09962	-1.172055164	6.027364945	387.7479	4.1476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	350	chr17	72949146	chr17:72949146	C	T	97	PASS	AN=2;DP=350	GT	0/1
chr17	73565171	73565171	T	C	exonic	LLGL2	.	nonsynonymous SNV	LLGL2:NM_001031803:exon13:c.T1435C:p.F479L,LLGL2:NM_004524:exon13:c.T1435C:p.F479L	8.27E-07	0.999084868	0.000914305	.	.	.	1.04528704	91.31280962	9919.23727	21.67473	0.788	0.032	T	0.0	0.026	B	0.0	0.013	B	0.000	0.497	N	0.999	0.216	P	-1.95	0.002	N	2.97	0.095	T	1.31	0.009	N	0.101	0.104	-1.019	0.241	T	0.000	0.000	T	.	.	.	0.764	0.167	9.237	0.965	0.294	0.563	0.298	D	c	-0.787	-0.561	0.000	0.059	0.696	0.567	0	4.33	0.509	2.054	0.407	0.069	0.176	1.000	0.715	0.956	0.434	2.731	0.049	WD40-repeat-containing domain	ENSG00000073350.9|ENSG00000073350.9	Cells_EBV-transformed_lymphocytes|Whole_Blood	0.5	96	282	chr17	73565171	chr17:73565171	T	C	96	PASS	AN=2;DP=282	GT	0/1
chr17	78087109	78087109	A	G	exonic	GAA	.	synonymous SNV	GAA:NM_000152:exon15:c.A2133G:p.T711T,GAA:NM_001079804:exon15:c.A2133G:p.T711T,GAA:NM_001079803:exon16:c.A2133G:p.T711T	4.62E-11	0.781839838	0.218160162	DISEASE: Glycogen storage disease 2 (GSD2) [MIM:232300]: A metabolic disorder with a broad clinical spectrum. The severe infantile form, or Pompe disease, presents at birth with massive accumulation of glycogen in muscle, heart and liver. Cardiomyopathy and muscular hypotonia are the cardinal features of this form whose life expectancy is less than two years. The juvenile and adult forms present as limb-girdle muscular dystrophy beginning in the lower limbs. Final outcome depends on respiratory muscle failure. Patients with the adult form can be free of clinical symptoms for most of their life but finally develop a slowly progressive myopathy. {ECO:0000269|PubMed:10189220, ECO:0000269|PubMed:10206684, ECO:0000269|PubMed:10338092, ECO:0000269|PubMed:10737124, ECO:0000269|PubMed:11071489, ECO:0000269|PubMed:11738358, ECO:0000269|PubMed:12601120, ECO:0000269|PubMed:12923862, ECO:0000269|PubMed:14643388, ECO:0000269|PubMed:14695532, ECO:0000269|PubMed:14972326, ECO:0000269|PubMed:15145338, ECO:0000269|PubMed:15668445, ECO:0000269|PubMed:16433701, ECO:0000269|PubMed:1652892, ECO:0000269|PubMed:16782080, ECO:0000269|PubMed:1684505, ECO:0000269|PubMed:16917947, ECO:0000269|PubMed:17643989, ECO:0000269|PubMed:18425781, ECO:0000269|PubMed:18429042, ECO:0000269|PubMed:1898413, ECO:0000269|PubMed:19588081, ECO:0000269|PubMed:20080426, ECO:0000269|PubMed:20350966, ECO:0000269|PubMed:21109266, ECO:0000269|PubMed:22644586, ECO:0000269|PubMed:22676651, ECO:0000269|PubMed:25681614, ECO:0000269|PubMed:7695647, ECO:0000269|PubMed:7717400, ECO:0000269|PubMed:7866409, ECO:0000269|PubMed:7881422, ECO:0000269|PubMed:7981676, ECO:0000269|PubMed:8094613, ECO:0000269|PubMed:8401535, ECO:0000269|PubMed:8834250, ECO:0000269|PubMed:9521422, ECO:0000269|PubMed:9535769, ECO:0000269|PubMed:9660056, ECO:0000269|Ref.5}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11717	0.93517	-1.159397299	6.098136353	1841.49194	7.915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	329	chr17	78087109	chr17:78087109	A	G	96	PASS	AN=2;DP=329	GT	0/1
chr17	78935197	78935197	C	T	exonic	RPTOR	.	synonymous SNV	RPTOR:NM_001163034:exon27:c.C3135T:p.R1045R,RPTOR:NM_020761:exon31:c.C3609T:p.R1203R	0.999999983	1.67E-08	4.96E-21	.	.	.	-2.583601763	0.831564048	64.74857	1.65128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	464	chr17	78935197	chr17:78935197	C	T	108	PASS	AN=2;DP=464	GT	0/1
chr17	79246270	79246270	-	C	intronic	SLC38A10	.	.	.	4.09E-08	0.986554606	0.013445353	.	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	143	67	chr17	79246270	chr17:79246270	G	GC	143	PASS	AN=2;DP=67	GT	0/1
chr18	14173952	14173952	A	G	intergenic	ZNF519;ANKRD20A5P	dist=41463;dist=5144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	135	chr18	14173952	chr18:14173952	A	G	110	PASS	AN=2;DP=135	GT	0/1
chr19	2399234	2399234	G	A	intronic	TMPRSS9	.	.	.	1.77E-18	0.011731011	0.988268989	.	0.07122	.	1.646179058	96.19013918	6013.59996	16.19227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	172	chr19	2399234	chr19:2399234	G	A	77	PASS	AN=2;DP=172	GT	0/1
chr19	3155902	3155902	G	A	exonic	GNA15	.	synonymous SNV	GNA15:NM_002068:exon5:c.G696A:p.L232L	0.306963812	0.689125446	0.003910742	.	0.06813	.	-0.490397599	22.50530786	101.86504	2.18376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	148	chr19	3155902	chr19:3155902	G	A	92	PASS	AN=2;DP=148	GT	0/1
chr19	4945914	4945914	A	C	exonic	UHRF1	.	unknown	UNKNOWN	.	.	.	DISEASE: Note=Defects in UHRF1 may be a cause of cancers. Overexpressed in many different forms of human cancers, including bladder, breast, cervical, colorectal and prostate cancers, as well as pancreatic adenocarcinomas, rhabdomyosarcomas and gliomas. Plays an important role in the correlation of histone modification and gene silencing in cancer progression. Expression is associated with a poor prognosis in patients with various cancers, suggesting that it participates in cancer progression.; 	0.23883	0.15269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	189	203	chr19	4945914	chr19:4945914	A	C	189	PASS	AN=2;DP=203	GT	0/1
chr19	7076418	7076418	C	A	exonic	ZNF557	.	synonymous SNV	ZNF557:NM_001044387:exon5:c.C147A:p.A49A,ZNF557:NM_001044388:exon5:c.C126A:p.A42A,ZNF557:NM_024341:exon5:c.C147A:p.A49A	1.51E-06	0.398872299	0.601126193	.	0.06637	0.06391	-0.179930907	40.35739561	78.21487	1.8653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	163	chr19	7076418	chr19:7076418	C	A	80	PASS	AN=2;DP=163	GT	0/1
chr19	11564674	11564674	-	T	UTR3	ELAVL3	NM_001420:c.*666_*667insA;NM_032281:c.*666_*667insA	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	279	chr19	11564674	chr19:11564674	G	GT	134	PASS	AN=2;DP=279	GT	0/1
chr19	13879622	13879622	T	C	intronic	MRI1	.	.	.	0.000533201	0.695290836	0.304175963	.	.	.	0.50895761	80.20169851	295.74482	3.672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	196	chr19	13879622	chr19:13879622	T	C	96	PASS	AN=2;DP=196	GT	0/1
chr19	15083485	15083485	T	C	intronic	SLC1A6	.	.	.	0.928911024	0.071012147	7.68E-05	.	0.26103	.	-0.800872469	12.33191791	38.46571	1.14105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	122	chr19	15083485	chr19:15083485	T	C	64	PASS	AN=2;DP=122	GT	0/1
chr19	15905468	15905468	T	G	exonic	OR10H5	.	nonsynonymous SNV	OR10H5:NM_001004466:exon1:c.T610G:p.C204G	0.043953004	0.666138751	0.289908245	.	0.05526	0.09533	1.910792163	97.4168436	5294.08243	15.03864	0.122	0.276	T	0.998	0.715	D	0.984	0.745	D	0.000	0.537	D	1	0.090	P	-1.72	0.003	N	1.29	0.358	T	-1.9	0.443	N	0.451	0.504	-1.088	0.058	T	0.002	0.008	T	.	.	.	0.506	0.142	7.473	0.698	0.088	0.110	0.161	N	c	-0.380	-0.506	0.000	0.060	0.487	0.133	0	3.36	0.374	1.173	0.313	0.719	0.303	0.001	0.137	0.003	0.074	6.761	0.226	GPCR, rhodopsin-like, 7TM	ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267453.2|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Frontal_Cortex_BA9|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Thyroid|Thyroid	0.5	158	162	chr19	15905468	chr19:15905468	T	G	158	PASS	AN=2;DP=162	GT	0/1
chr19	15905505	15905505	T	C	exonic	OR10H5	.	nonsynonymous SNV	OR10H5:NM_001004466:exon1:c.T647C:p.L216P	0.043953004	0.666138751	0.289908245	.	0.05526	0.09533	1.910792163	97.4168436	5294.08243	15.03864	0.006	0.614	D	0.997	0.689	D	0.976	0.719	D	0.012	0.295	N	0.001	0.452	P	2.91	0.844	M	8.34	0.003	T	-4.57	0.787	D	0.262	0.350	-0.887	0.492	T	0.000	0.000	T	.	.	.	4.084	0.548	23.7	0.998	0.921	0.768	0.374	D	c	0.407	0.224	0.022	0.135	0.487	0.133	0	3.88	0.438	2.676	0.463	0.719	0.303	0.038	0.207	0.022	0.137	10.953	0.464	GPCR, rhodopsin-like, 7TM	ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267453.2|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Frontal_Cortex_BA9|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Thyroid|Thyroid	0.5	159	169	chr19	15905505	chr19:15905505	T	C	159	PASS	AN=2;DP=169	GT	0/1
chr19	18375846	18375846	G	A	exonic	KIAA1683	.	nonsynonymous SNV	KIAA1683:NM_001145304:exon3:c.C2504T:p.P835L,KIAA1683:NM_001145305:exon3:c.C2366T:p.P789L,KIAA1683:NM_025249:exon3:c.C2504T:p.P835L	8.28E-06	0.980911152	0.019080563	.	0.07923	0.08035	3.760579722	99.61075725	2365.24197	9.02868	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.012	0.293	N	1	0.090	P	-2.11	0.002	N	4.42	0.024	T	2.5	0.002	N	0.026	0.064	-1.012	0.262	T	0.000	0.000	T	.	.	.	0.036	0.097	2.942	0.209	0.008	0.000	0.002	N	c	-1.263	-1.171	0.939	0.273	0.421	0.056	0	4.29	0.502	1.498	0.350	0.202	0.252	0.004	0.165	0.002	0.062	6.905	0.233	.	.	.	0.5	83	244	chr19	18375846	chr19:18375846	G	A	83	PASS	AN=2;DP=244	GT	0/1
chr19	38956803	38956803	G	A	exonic	RYR1	.	synonymous SNV	RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	280	chr19	38956803	chr19:38956803	G	A	88	PASS	AN=2;DP=280	GT	0/1
chr19	40322456	40322456	C	T	exonic	DYRK1B	.	nonsynonymous SNV	DYRK1B:NM_004714:exon2:c.G52A:p.E18K,DYRK1B:NM_006483:exon2:c.G52A:p.E18K,DYRK1B:NM_006484:exon2:c.G52A:p.E18K	0.915927122	0.084048961	2.39E-05	DISEASE: Abdominal obesity-metabolic syndrome 3 (AOMS3) [MIM:615812]: A form of abdominal obesity-metabolic syndrome, a disorder characterized by abdominal obesity, high triglycerides, low levels of high density lipoprotein cholesterol, high blood pressure, and elevated fasting glucose levels. AOMS3 is characterized by early-onset coronary artery disease, central obesity, hypertension, and diabetes. {ECO:0000269|PubMed:24827035}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65474	0.16753	-0.844966979	11.1759849	75.91525	1.8259	0.039	0.440	D	0.88	0.464	P	0.899	0.620	P	0.000	0.466	D	0.749	0.339	D	1.04	0.263	L	0.46	0.563	T	-0.93	0.253	N	0.674	0.684	-0.876	0.501	T	0.140	0.460	T	0.023	0.460	T	6.639	0.911	32	0.999	0.986	0.957	0.657	D	c	0.126	0.208	1.000	0.747	0.646	0.450	0	4.06	0.464	4.015	0.566	0.935	0.490	1.000	0.715	1.000	0.888	11.950	0.520	.	.	.	0.5	120	264	chr19	40322456	chr19:40322456	C	T	120	PASS	AN=2;DP=264	GT	0/1
chr19	41354661	41354661	T	C	exonic	CYP2A6	.	synonymous SNV	CYP2A6:NM_000762:exon3:c.A351G:p.V117V	2.18E-06	0.708893749	0.291104073	.	0.23228	0.52146	0.295774947	71.64425572	375.34434	4.08402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	274	chr19	41354661	chr19:41354661	T	C	146	PASS	AN=2;DP=274	GT	0/1
chr19	41415923	41415923	G	A	intergenic	CYP2G1P;CYP2B7P	dist=9510;dist=14247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	149	chr19	41415923	chr19:41415923	G	A	68	PASS	AN=2;DP=149	GT	0/1
chr19	43411230	43411230	C	G	exonic	PSG6	.	nonsynonymous SNV	PSG6:NM_001031850:exon5:c.G1084C:p.E362Q,PSG6:NM_002782:exon5:c.G1084C:p.E362Q	2.97E-09	0.16039048	0.839609517	.	0.26273	.	2.166192036	98.0301958	170.30147	2.8473	0.566	0.063	T	0.05	0.211	B	0.124	0.310	B	.	.	.	1	0.090	N	-1.23	0.008	N	2.73	0.119	T	0.02	0.073	N	0.157	0.188	-0.913	0.465	T	0.002	0.007	T	.	.	.	-1.458	0.018	0.003	0.091	0.001	0.000	0.001	N	c	-1.638	-1.675	0.000	0.029	0.487	0.133	0	0.383	0.154	0.193	0.168	-3.193	0.001	0.004	0.165	0.002	0.062	5.830	0.177	Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	95	88	chr19	43411230	chr19:43411230	C	G	95	PASS	AN=2;DP=88	GT	0/1
chr19	43586637	43586637	C	T	intronic	PSG2	.	.	.	6.19E-07	0.441195774	0.558803607	.	0.07772	.	1.401792296	94.75112055	126.24057	2.44595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	144	chr19	43586637	chr19:43586637	C	T	67	PASS	AN=2;DP=144	GT	0/1
chr19	49558211	49558211	T	G	exonic	CGB7	.	nonsynonymous SNV	CGB7:NM_033142:exon2:c.A70C:p.M24L	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	0.731	0.038	T	.	.	.	.	.	.	0.985	0.079	N	1	0.090	N	.	.	.	1.18	0.377	T	-0.25	0.110	N	0.162	0.195	-1.021	0.234	T	0.000	0.000	T	.	.	.	-1.685	0.013	0.002	0.447	0.034	0.000	0.003	N	c	-0.919	-1.061	0.226	0.184	0.677	0.550	0	0.946	0.186	2.839	0.477	-0.104	0.116	0.727	0.287	0.001	0.043	5.899	0.181	.	ENSG00000196337.6|ENSG00000196337.6|ENSG00000196337.6|ENSG00000196337.6|ENSG00000104827.12|ENSG00000189052.6|ENSG00000196337.6|ENSG00000189052.6|ENSG00000213030.4|ENSG00000189052.6|ENSG00000196337.6|ENSG00000213030.4|ENSG00000196337.6	Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Pancreas|Prostate|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis	0.5	141	367	chr19	49558211	chr19:49558211	T	G	141	PASS	AN=2;DP=367	GT	0/1
chr19	50462298	50462298	G	C	exonic	SIGLEC11	.	nonsynonymous SNV	SIGLEC11:NM_001135163:exon6:c.C1094G:p.A365G,SIGLEC11:NM_052884:exon6:c.C1094G:p.A365G	2.64E-08	0.478412852	0.521587121	.	0.07542	0.08273	0.846940207	88.47605567	1686.30736	7.57044	0.194	0.208	T	0.166	0.269	B	0.169	0.336	B	0.818	0.092	N	1	0.090	P	-0.13	0.045	N	0.54	0.549	T	-1.88	0.439	N	0.052	0.068	-0.957	0.398	T	0.000	0.000	T	.	.	.	0.740	0.165	9.088	0.912	0.199	0.001	0.008	N	c	-0.723	-0.853	0.000	0.052	0.554	0.283	0	-1.51	0.082	-0.502	0.064	-0.143	0.109	0.000	0.063	0.051	0.165	2.921	0.054	Immunoglobulin-like domain	ENSG00000161640.11|ENSG00000161640.11|ENSG00000161640.11|ENSG00000161640.11|ENSG00000105053.6|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11	Breast_Mammary_Tissue|Colon_Transverse|Lung|Nerve_Tibial|Testis|Testis|Testis|Whole_Blood	0.5	83	104	chr19	50462298	chr19:50462298	G	C	83	PASS	AN=2;DP=104	GT	0/1
chr19	52472295	52472295	A	G	exonic	ZNF350	.	synonymous SNV	ZNF350:NM_021632:exon3:c.T105C:p.D35D	0.000264162	0.930339407	0.069396431	.	0.21884	0.16743	0.843299698	88.37579618	1379.50737	6.95828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	191	chr19	52472295	chr19:52472295	A	G	91	PASS	AN=2;DP=191	GT	0/1
chr19	53875494	53875494	A	T	UTR5	ZNF525	NM_001348156:c.-41A>T	.	.	0.001291108	0.856656613	0.142052279	.	.	.	.	.	19.03117	0.65731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	69	chr19	53875494	chr19:53875494	A	T	69	PASS	AN=2;DP=69	GT	0/1
chr19	53875523	53875523	G	A	UTR5	ZNF525	NM_001348156:c.-12G>A	.	.	0.001291108	0.856656613	0.142052279	.	.	.	.	.	19.03117	0.65731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	85	chr19	53875523	chr19:53875523	G	A	72	PASS	AN=2;DP=85	GT	0/1
chr19	53875569	53875569	G	A	intronic	ZNF525	.	.	.	0.001291108	0.856656613	0.142052279	.	.	.	.	.	19.03117	0.65731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	105	chr19	53875569	chr19:53875569	G	A	88	PASS	AN=2;DP=105	GT	0/1
chr19	55098667	55098667	G	A	splicing	LILRA2	NM_001290271:exon9:c.1515-1G>A;NM_001290271:exon9:UTR3;NM_006866:exon8:c.1256-1G>A;NM_001290270:exon6:c.1220-1G>A;NM_001130917:exon8:c.1307-1G>A	.	.	6.89E-12	0.017769701	0.982230299	.	0.21687	.	3.228703513	99.37485256	778.15005	5.5191	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.191	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.617	0.014	0.002	0.498	0.042	0.002	0.013	N	c	-0.406	-0.904	0.016	0.128	0.075	0.014	0	-2.44	0.061	-4.641	0.002	-0.714	0.037	0.000	0.063	0.000	0.016	0.509	0.005	.	.	.	0.5	86	170	chr19	55098667	chr19:55098667	G	A	86	PASS	AN=2;DP=170	GT	0/1
chr19	55106317	55106317	A	G	exonic	LILRA1	.	synonymous SNV	LILRA1:NM_001278319:exon3:c.A258G:p.P86P,LILRA1:NM_001278318:exon4:c.A258G:p.P86P,LILRA1:NM_006863:exon4:c.A258G:p.P86P	1.54E-16	0.000861763	0.999138237	.	0.03809	.	2.539299607	98.72021703	2966.18722	10.32448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	139	chr19	55106317	chr19:55106317	A	G	69	PASS	AN=2;DP=139	GT	0/1
chr19	56572875	56572875	G	A	exonic	NLRP5	.	nonsynonymous SNV	NLRP5:NM_153447:exon15:c.G3584A:p.R1195Q	1.24E-07	0.997190144	0.002809732	.	0.05999	.	0.179893931	66.1358811	2994.59421	10.38714	0.224	0.187	T	0.994	0.647	D	0.537	0.469	P	.	.	.	1	0.090	P	1.645	0.421	L	-0.65	0.722	T	-1.08	0.281	N	0.047	0.028	-1.059	0.119	T	0.000	0.000	T	.	.	.	2.129	0.317	17.04	0.998	0.902	0.017	0.054	N	c	-0.327	-0.511	0.000	0.012	0.487	0.133	0	-0.022	0.132	0.536	0.227	0.784	0.316	0.022	0.197	0.745	0.320	3.739	0.080	.	.	.	0.5	69	78	chr19	56572875	chr19:56572875	G	A	69	PASS	AN=2;DP=78	GT	0/1
chr20	4228872	4228872	A	G	exonic	ADRA1D	.	nonsynonymous SNV	ADRA1D:NM_000678:exon1:c.T733C:p.F245L	.	.	.	.	0.14449	0.11771	0.156217551	64.82071243	229.7736	3.27584	0.7	0.042	T	0.153	0.265	B	0.27	0.381	B	0.002	0.380	U	0.979	0.252	N	-0.105	0.046	N	1.12	0.387	T	-0.32	0.123	N	0.374	0.435	-0.981	0.347	T	0.055	0.232	T	0.008	0.202	T	1.435	0.235	12.97	0.968	0.304	0.827	0.416	D	c	-0.323	-0.139	1.000	0.747	0.765	0.991	0	4.25	0.495	2.090	0.411	1.197	0.919	1.000	0.715	1.000	0.888	7.069	0.242	GPCR, rhodopsin-like, 7TM	.	.	0.5	159	230	chr20	4228872	chr20:4228872	A	G	159	PASS	AN=2;DP=230	GT	0/1
chr20	29628185	29628185	A	G	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	297	chr20	29628185	chr20:29628185	A	G	102	PASS	AN=2;DP=297	GT	0/1
chr20	29632632	29632632	A	G	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	270	chr20	29632632	chr20:29632632	A	G	132	PASS	AN=2;DP=270	GT	0/1
chr20	29632643	29632643	T	C	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	0.027	0.465	D	0.481	0.349	P	0.317	0.399	B	0.000	0.843	U	1	0.810	D	.	.	.	.	.	.	-4.78	0.805	D	0.829	0.817	-0.847	0.522	T	0.162	0.498	T	.	.	.	4.063	0.546	23.7	0.990	0.494	0.869	0.460	D	c	0.008	-0.014	1.000	0.747	0.675	0.547	0	1.44	0.215	6.853	0.751	0.574	0.285	1.000	0.715	0.999	0.750	6.983	0.237	.	.	.	0.5	141	286	chr20	29632643	chr20:29632643	T	C	141	PASS	AN=2;DP=286	GT	0/1
chr20	46294828	46294828	T	C	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	185	chr20	46294828	chr20:46294828	T	C	106	PASS	AN=2;DP=185	GT	0/1
chr21	11021097	11021097	G	T	intronic	BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	182	chr21	11021097	chr21:11021097	G	T	103	PASS	AN=2;DP=182	GT	0/1
chr21	11049617	11049617	C	G	exonic	BAGE2;BAGE3	.	nonsynonymous SNV	BAGE3:NM_182481:exon4:c.G284C:p.R95T,BAGE2:NM_182482:exon4:c.G284C:p.R95T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	178	chr21	11049617	chr21:11049617	C	G	126	PASS	AN=2;DP=178	GT	0/1
chr21	11049623	11049623	T	C	splicing	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:exon4:c.280-2A>G;NM_182481:exon4:c.280-2A>G;NM_181704:exon4:c.285-2A>G;NM_181704:exon4:UTR3;NM_182484:exon4:c.284-2A>G;NM_182484:exon4:UTR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	177	chr21	11049623	chr21:11049623	T	C	137	PASS	AN=2;DP=177	GT	0/1
chr21	14439357	14439357	C	G	ncRNA_exonic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	46	chr21	14439357	chr21:14439357	C	G	82	PASS	AN=2;DP=46	GT	0/1
chr21	14722780	14722780	A	G	intergenic	ANKRD30BP2;MIR3156-3	dist=232209;dist=55925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	118	chr21	14722780	chr21:14722780	A	G	71	PASS	AN=2;DP=118	GT	0/1
chr21	30257560	30257560	C	G	exonic	N6AMT1	.	synonymous SNV	N6AMT1:NM_013240:exon1:c.G108C:p.L36L,N6AMT1:NM_182749:exon1:c.G108C:p.L36L	0.009871785	0.821358578	0.168769637	.	0.48968	0.09594	0.72761005	86.08162302	1301.02352	6.78541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	285	chr21	30257560	chr21:30257560	C	G	95	PASS	AN=2;DP=285	GT	0/1
chr21	46011687	46011687	C	T	exonic	KRTAP10-6	.	nonsynonymous SNV	KRTAP10-6:NM_198688:exon1:c.G679A:p.A227T	1.55E-05	0.242389557	0.757594911	.	.	.	3.24344868	99.38664779	6418.15237	16.78541	0.5	0.077	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	P	1.085	0.274	L	5.04	0.013	T	-1.74	0.412	N	0.023	0.006	-0.929	0.443	T	0.000	0.000	T	.	.	.	-0.650	0.047	0.094	0.752	0.106	0.010	0.037	N	c	-2.148	-2.281	0.515	0.210	0.526	0.212	0	-5.22	0.026	-5.836	0.001	-3.543	0.001	0.000	0.063	0.000	0.016	1.403	0.021	.	ENSG00000188155.8	Testis	0.5	81	211	chr21	46011687	chr21:46011687	C	T	81	PASS	AN=2;DP=211	GT	0/1
chr21	46913477	46913477	G	C	exonic	COL18A1	.	nonsynonymous SNV	COL18A1:NM_030582:exon25:c.G2880C:p.Q960H,COL18A1:NM_130444:exon25:c.G3585C:p.Q1195H,COL18A1:NM_130445:exon26:c.G2340C:p.Q780H	1.24E-05	0.999986852	7.71E-07	DISEASE: Knobloch syndrome 1 (KNO1) [MIM:267750]: A developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia. {ECO:0000269|PubMed:10942434, ECO:0000269|PubMed:23667181}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35149	.	0.743953846	86.36470866	5515.49068	15.31657	0.25	0.285	T	0.011	0.147	B	0.012	0.149	B	0.621	0.108	N	1.000	0.197	P	1.88	0.501	L	-3.22	0.934	D	-1.79	0.488	N	0.063	0.091	-0.854	0.517	T	0.011	0.044	T	.	.	.	0.508	0.143	7.491	0.993	0.576	0.061	0.120	N	c	-0.944	-0.958	0.739	0.232	0.707	0.730	0	0.37	0.153	0.360	0.198	0.998	0.613	0.013	0.187	0.959	0.439	6.075	0.190	.	.	.	0.5	98	256	chr21	46913477	chr21:46913477	G	C	98	PASS	AN=2;DP=256	GT	0/1
chr21	46925161	46925161	G	C	exonic	COL18A1	.	synonymous SNV	COL18A1:NM_030582:exon35:c.G3513C:p.G1171G,COL18A1:NM_130444:exon35:c.G4218C:p.G1406G,COL18A1:NM_130445:exon36:c.G2973C:p.G991G	1.24E-05	0.999986852	7.71E-07	DISEASE: Knobloch syndrome 1 (KNO1) [MIM:267750]: A developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia. {ECO:0000269|PubMed:10942434, ECO:0000269|PubMed:23667181}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35149	.	0.743953846	86.36470866	5515.49068	15.31657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	198	chr21	46925161	chr21:46925161	G	C	91	PASS	AN=2;DP=198	GT	0/1
chr21	47545823	47545823	G	A	exonic	COL6A2	.	synonymous SNV	COL6A2:NM_001849:exon26:c.G2094A:p.A698A,COL6A2:NM_058174:exon26:c.G2094A:p.A698A,COL6A2:NM_058175:exon26:c.G2094A:p.A698A	0.002133757	0.99785937	6.87E-06	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:11865138, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:8782832}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15563506, ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myosclerosis autosomal recessive (MYOSAR) [MIM:255600]: A condition characterized by chronic inflammation of skeletal muscle with hyperplasia of the interstitial connective tissue. The clinical picture includes slender muscles with firm 'woody' consistency and restriction of movement of many joints because of muscle contractures. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.50744	0.37851	-1.001964775	8.221278603	5707.29483	15.65413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	274	chr21	47545823	chr21:47545823	G	A	103	PASS	AN=2;DP=274	GT	0/1
chr22	18973471	18973471	T	C	ncRNA_intronic	DGCR5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	142	chr22	18973471	chr22:18973471	T	C	77	PASS	AN=2;DP=142	GT	0/1
chr22	29837537	29837537	T	C	exonic	RFPL1	.	nonsynonymous SNV	RFPL1:NM_021026:exon2:c.T380C:p.M127T	0.00732601	0.770811708	0.221862282	.	0.09815	.	1.396334339	94.70393961	6338.15844	16.66012	0.034	0.440	D	0.982	0.581	D	0.998	0.875	D	.	.	.	0.990	0.242	P	2.89	0.840	M	2.87	0.104	T	-3.43	0.673	D	0.123	0.138	-0.959	0.394	T	0.000	0.000	T	.	.	.	3.716	0.504	23.3	0.980	0.369	0.816	0.407	D	c	0.162	-0.104	0.020	0.132	0.554	0.246	0	1.1	0.195	4.972	0.632	0.443	0.277	0.996	0.391	0.326	0.242	6.312	0.202	B30.2/SPRY domain|Butyrophylin-like|Concanavalin A-like lectin/glucanase domain|SPRY-associated	ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9	Adipose_Subcutaneous|Artery_Tibial|Breast_Mammary_Tissue|Esophagus_Muscularis|Lung|Muscle_Skeletal|Skin_Sun_Exposed_Lower_leg|Thyroid	0.5	68	82	chr22	29837537	chr22:29837537	T	C	68	PASS	AN=2;DP=82	GT	0/1
chr22	42276742	42276742	G	C	exonic	SREBF2	.	nonsynonymous SNV	SREBF2:NM_004599:exon10:c.G1784C:p.G595A	0.996271601	0.003728398	4.39E-10	.	0.65981	0.47389	-1.831803113	2.093654164	3329.62947	11.03522	0.873	0.026	T	0.0	0.026	B	0.0	0.013	B	0.058	0.225	N	1	0.090	P	-0.49	0.026	N	2.24	0.179	T	1.32	0.009	N	0.023	0.006	-0.968	0.376	T	0.000	0.000	T	.	.	.	0.476	0.140	7.244	0.797	0.124	0.108	0.160	N	c	-0.836	-0.599	0.548	0.213	0.707	0.730	0	4.95	0.648	1.073	0.301	0.032	0.150	0.742	0.288	0.867	0.362	6.559	0.215	.	ENSG00000183172.8|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000183172.8|ENSG00000100417.7|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000183172.8|ENSG00000100147.9|ENSG00000183172.8	Adipose_Subcutaneous|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Colon_Transverse|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Lung|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Skin_Sun_Exposed_Lower_leg|Thyroid|Thyroid|Whole_Blood	0.5	89	217	chr22	42276742	chr22:42276742	G	C	89	PASS	AN=2;DP=217	GT	0/1
chr22	50696648	50696648	C	T	intronic	MAPK12	.	.	.	0.013620058	0.979692625	0.006687317	DISEASE: Note=MAPK is overexpressed in highly metastatic breast cancer cell lines and its expression is preferentially associated with basal-like and metastatic phenotypes of breast tumor samples.; 	0.4586	0.43657	-0.354480518	29.42911064	776.33339	5.51752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	265	chr22	50696648	chr22:50696648	C	T	88	PASS	AN=2;DP=265	GT	0/1
chrX	24807159	24807159	C	T	intronic	POLA1	.	.	.	0.999999525	4.75E-07	1.72E-17	.	0.99571	0.30271	-0.795417163	12.5324369	61.5917	1.59962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	238	chrX	24807159	chrX:24807159	C	T	107	PASS	AN=2;DP=238	GT	0/1
chrX	48163734	48163734	C	-	ncRNA_exonic	SSX9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	75	chrX	48163733	chrX:48163733	TC	T	48	PASS	AN=2;DP=75	GT	0/1
chrX	140785696	140785696	T	C	exonic	SPANXC;SPANXD	.	nonsynonymous SNV	SPANXC:NM_022661:exon2:c.A220G:p.K74E,SPANXD:NM_032417:exon2:c.A220G:p.K74E	.	.	.	.	.	.	.	.	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	.	.	.	3.77	0.039	T	2.67	0.002	N	0.056	0.188	-0.945	0.419	T	0.004	0.015	T	.	.	.	-0.855	0.038	0.032	0.115	0.002	0.000	0.002	N	.	.	.	0.000	0.035	.	.	.	.	.	-2.052	0.015	-1.826	0.006	0.005	0.169	0.004	0.083	.	.	.	.	.	0.5	83	144	chrX	140785696	chrX:140785696	T	C	83	PASS	AN=2;DP=144	GT	0/1
chrX	140785714	140785714	C	G	exonic	SPANXC;SPANXD	.	nonsynonymous SNV	SPANXC:NM_022661:exon2:c.G202C:p.V68L,SPANXD:NM_032417:exon2:c.G202C:p.V68L	.	.	.	.	.	.	.	.	.	.	0.991	0.020	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	N	.	.	.	3.23	0.070	T	-1.26	0.318	N	0.082	0.230	-0.921	0.454	T	0.009	0.031	T	.	.	.	-0.583	0.051	0.137	0.204	0.007	0.002	0.011	N	.	.	.	0.000	0.012	.	.	.	.	.	0.064	0.142	0.079	0.188	0.016	0.191	0.017	0.128	.	.	.	.	.	0.5	83	145	chrX	140785714	chrX:140785714	C	G	83	PASS	AN=2;DP=145	GT	0/1
chrX	140993912	140993912	C	T	exonic	MAGEC1	.	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C722T:p.S241F	.	.	.	.	0.03644	.	6.421180534	99.87025242	4106.66315	12.72208	0.935	0.022	T	0.001	0.067	B	0.0	0.013	B	.	.	.	0.999	0.588	P	0.345	0.112	N	4.3	0.025	T	-0.38	0.134	N	0.184	0.323	-0.929	0.443	T	0.000	0.000	T	.	.	.	0.015	0.095	2.732	0.175	0.005	0.007	0.030	N	.	.	.	0.000	0.029	.	.	.	.	.	-0.253	0.087	-2.027	0.005	0.000	0.063	0.000	0.016	2.669	0.047	.	.	.	0.5	78	116	chrX	140993912	chrX:140993912	C	T	78	PASS	AN=2;DP=116	GT	0/1
